Vorinostat (SAHA)

For research use only. Not for use in humans.

目录号：S1047 别名： MK0683

Molecular Weight(MW): 264.3

Vorinostat (suberoylanilide hydroxamic acid, SAHA)是一种HDAC抑制剂，无细胞试验中IC50为~10 nM。Vorinostat 会抑制高效的HPV-18 DNA扩增。

规格

价格

库存

购买数量

10mM (1mL in DMSO)	RMB 1558.77	现货
200mg	RMB 1198.15	现货
500mg	RMB 1794.86	现货
大包装	有超大折扣

大剂量询单有大折扣！

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck生产的Vorinostat (SAHA)发表文献309篇：

Nat Biotechnol, 2020, 10.1038/s41587-019-0388-4

PubMed: 31959954 ( click the link to review the publication )

Cancer Cell, 2020, 13;37(4):599-617 e7

PubMed: 32243837 ( click the link to review the publication )

Cell, 2019, 176(1-2):198-212

PubMed: 30503211 ( click the link to review the publication )

Cell, 2019, 36(2):179-193

PubMed: 28162770 ( click the link to review the publication )

Cancer Cell, 2019, 36(2):179-193

PubMed: 31378681 ( click the link to review the publication )

Cell, 2018, 174(3):536-548.e21

PubMed: 29961578 ( click the link to review the publication )

Cell Metab, 2018, 5;27(6):1294-1308.e7

PubMed: 29754954 ( click the link to review the publication )

Nature, 2017, 551(7679):247-250

PubMed: 29088702 ( click the link to review the publication )

Cancer Discov, 2017, 7(12):1450-1463

PubMed: 28963352 ( click the link to review the publication )

Cancer Cell, 2016, 29(3):311-323

PubMed: 26977882 ( click the link to review the publication )

Nat Biotechnol, 2015, 10.1038/nbt.3130

PubMed: 25751058 ( click the link to review the publication )

Nat Med, 2015, 21(10):1163-71

PubMed: 26390243 ( click the link to review the publication )

Nat Med, 2015, 10.1038/nm.3855

PubMed: 25939062 ( click the link to review the publication )

Cell, 2014, 28;158(5):989-999.

PubMed: 25131989 ( click the link to review the publication )

Nature, 2011, 10;471(7337):235-9.

PubMed: 21390130 ( click the link to review the publication )

Nat Biotechnol, 2011, 29(3):255-65

PubMed: 21258344 ( click the link to review the publication )

Nucleic Acids Res, 2020, 10.1093/nar/gkaa088

PubMed: 32107550 ( click the link to review the publication )

EMBO Rep, 2020, 21:e50162

PubMed: 32314873 ( click the link to review the publication )

J Immunother Cancer, 2020, 8(1)

PubMed: 31940587 ( click the link to review the publication )

Theranostics, 2020, 1;10(3):1433-1453

PubMed: 31938073 ( click the link to review the publication )

Cancer, 2020, 1;126(9):2024-2033

PubMed: 31999837 ( click the link to review the publication )

PLoS Pathog, 2020, 16;16(3):e1008341

PubMed: 32176725 ( click the link to review the publication )

Clin Epigenetics, 2020, 12(1):13

PubMed: 31941522 ( click the link to review the publication )

Br J Cancer, 2020, 27

PubMed: 32336756 ( click the link to review the publication )
Front Cell Dev Biol, 2020, 17;8:158

PubMed: 32258036 ( click the link to review the publication )

J Neuroinflammation, 2020, 22;17(1):125

PubMed: 32321538 ( click the link to review the publication )

ACS Infect Dis, 2020, 29

PubMed: 32347704 ( click the link to review the publication )

Mol Cancer Res, 2020, 10.1158/1541-7786.MCR-19-0669

PubMed: 32238439 ( click the link to review the publication )

Front Oncol, 2020, 10:296

PubMed: 32195191 ( click the link to review the publication )

J Virol, 2020, 4;94(10) pii: e01923-19

PubMed: 32161174 ( click the link to review the publication )

Biochem Pharmacol, 2020, 3;178:114067

PubMed: 32504550 ( click the link to review the publication )

Cancer Cell Int, 2020, 19;20:58

PubMed: 32099531 ( click the link to review the publication )

BMC Microbiol, 2020, 20(1):28

PubMed: 32028887 ( click the link to review the publication )

PLoS One, 2020, 15;15(5):e0232985

PubMed: 32413049 ( click the link to review the publication )

Oncol Lett, 2020, 19(1):460-468

PubMed: 31897159 ( click the link to review the publication )

Colloids Surf B Biointerfaces, 2020, 188:110753

PubMed: 31884084 ( click the link to review the publication )

Mol Cancer Ther, 2020, 19(2):637-649

PubMed: 31784455 ( click the link to review the publication )

Genes Dev, 2020, 34(5-6):428-445

PubMed: 32001510 ( click the link to review the publication )

Life Sci, 2020, 248:117469

PubMed: 32109485 ( click the link to review the publication )

Chin Med J (Engl), 2020, 5;133(11):1304-1311

PubMed: 32452893 ( click the link to review the publication )

Pharm Biol, 2020, 58(1):231-238

PubMed: 32202448 ( click the link to review the publication )

Nat Commun, 2019, 10(1):4192

PubMed: 31519896 ( click the link to review the publication )

J Pineal Res, 2019, 66(3):e12556

PubMed: 30648757 ( click the link to review the publication )

Haematologica, 2019, 10.3324/haematol.2018.211110

PubMed: 30846494 ( click the link to review the publication )

Haematologica, 2019, 104(11):2225-2240

PubMed: 30819918 ( click the link to review the publication )

Theranostics, 2019, 9(2):540-553

PubMed: 30809292 ( click the link to review the publication )

Cancer Res, 2019, 79(7):1658-1670

PubMed: 30737231 ( click the link to review the publication )

Cell Rep, 2019, 27(11):3331-3344

PubMed: 31189115 ( click the link to review the publication )
Elife, 2019, 8

PubMed: 30652970 ( click the link to review the publication )

Mol Ther, 2019, 27(5):1039-1050

PubMed: 30852137 ( click the link to review the publication )

Cancers (Basel), 2019, 11(4)

PubMed: 30935067 ( click the link to review the publication )

Clin Epigenetics, 2019, 11(1):85

PubMed: 31142371 ( click the link to review the publication )

Acta Pharm Sin B, 2019, 9(5):937-951

PubMed: 31649844 ( click the link to review the publication )

Cells, 2019, 8(12)

PubMed: 31795298 ( click the link to review the publication )

Cancer Discov, 2019, 9(4):526-545

PubMed: 30709805 ( click the link to review the publication )

Front Immunol, 2019, 9:3162

PubMed: 30723480 ( click the link to review the publication )

Mol Cancer Ther, 2019, 18(5):900-908

PubMed: 30824609 ( click the link to review the publication )

Mol Oncol, 2019, 10.1002/1878-0261.12607

PubMed: 31782885 ( click the link to review the publication )

Epigenetics, 2019, 10.1080/15592294.2019.1656155

PubMed: 31423895 ( click the link to review the publication )

Epigenetics, 2019, 14(8):791-803

PubMed: 31088315 ( click the link to review the publication )

Epigenetics, 2019, 10.1080/15592294.2019.1656156

PubMed: 31423932 ( click the link to review the publication )

AIDS, 2019, 33(2):199-209

PubMed: 30562171 ( click the link to review the publication )

Hum Mol Genet, 2019, 10.1093/hmg/ddz254

PubMed: 31691806 ( click the link to review the publication )

Pharmacol Res, 2019, 139:524-534

PubMed: 30366100 ( click the link to review the publication )

Pharmacol Res, 2019, 146:104281

PubMed: 31125601 ( click the link to review the publication )

J Neurochem, 2019, 10.1111/jnc.14935

PubMed: 31811660 ( click the link to review the publication )

Mol Pharm, 2019, 16(9):3904-3915

PubMed: 31318566 ( click the link to review the publication )

Bone, 2019, 125:112-121

PubMed: 31100533 ( click the link to review the publication )

Front Cell Neurosci, 2019, 13:468

PubMed: 31708743 ( click the link to review the publication )

Int J Mol Sci, 2019, 20(13)

PubMed: 31269745 ( click the link to review the publication )

Apoptosis, 2019, 24(5-6):404-413

PubMed: 30997620 ( click the link to review the publication )

J Biol Chem, 2019, 294(12):4437-4449

PubMed: 30670592 ( click the link to review the publication )
Acta Pharmacol Sin, 2019, 40(5):677-688

PubMed: 30224636 ( click the link to review the publication )

NMR Biomed, 2019, 32(2):e4044

PubMed: 30561869 ( click the link to review the publication )

Stem Cells Dev, 2019, 28(7):438-453

PubMed: 30667343 ( click the link to review the publication )

Chem Biol Interact, 2019, 306:54-61

PubMed: 30958996 ( click the link to review the publication )

Gene Ther, 2019, 26(3-4):75-85

PubMed: 30538307 ( click the link to review the publication )

Cancer Med, 2019, 8(14):6383-6392

PubMed: 31456359 ( click the link to review the publication )

Tuberculosis (Edinb), 2019, 118:101861

PubMed: 31526947 ( click the link to review the publication )

PLoS One, 2019, 14(6):e0218382

PubMed: 31206526 ( click the link to review the publication )

Exp Hematol, 2019, 72:60-71

PubMed: 30769020 ( click the link to review the publication )

Nucl Med Biol, 2019, 74-75:1-11

PubMed: 31421440 ( click the link to review the publication )

Alcohol, 2019, 78:79-87

PubMed: 30851364 ( click the link to review the publication )

Anticancer Res, 2019, 39(7):3579-3584

PubMed: 31262882 ( click the link to review the publication )

Res Vet Sci, 2019, 126:207-212

PubMed: 31610471 ( click the link to review the publication )

Exp Ther Med, 2019, 17(6):4547-4553

PubMed: 31186678 ( click the link to review the publication )

Medicina (Kaunas), 2019, 55(2)

PubMed: 30700046 ( click the link to review the publication )

Cell Host Microbe, 2018, 24(5):689-702

PubMed: 30344003 ( click the link to review the publication )

Nat Commun, 2018, 13;9(1):2720

PubMed: 30006524 ( click the link to review the publication )

Clin Cancer Res, 2018, 24(16):3941-3954

PubMed: 29764852 ( click the link to review the publication )

Cancer Res, 2018, 78(10):2705-2720

PubMed: 29490948 ( click the link to review the publication )

J Control Release, 2018, 275:117-128

PubMed: 29474960 ( click the link to review the publication )

Haematologica, 2018, 103(4):679-687

PubMed: 29305415 ( click the link to review the publication )

J Hematol Oncol, 2018, 11(1):32

PubMed: 29486795 ( click the link to review the publication )

Cancer Lett, 2018, 432:121-131

PubMed: 29890207 ( click the link to review the publication )

Acta Biomater, 2018, 71:261-270

PubMed: 29526828 ( click the link to review the publication )
Sci Signal, 2018, 11(557)

PubMed: 30459282 ( click the link to review the publication )

J Exp Clin Cancer Res, 2018, 37(1):153

PubMed: 30012171 ( click the link to review the publication )

Mol Cancer Ther, 2018, 17(12):2767-2779

PubMed: 30232145 ( click the link to review the publication )

J Virol, 2018, 92(10)

PubMed: 29343578 ( click the link to review the publication )

J Virol, 2018, 92(6)

PubMed: 29298886 ( click the link to review the publication )

J Cell Mol Med, 2018, 22(5):2600-2611

PubMed: 29461008 ( click the link to review the publication )

Sci Rep, 2018, 8(1):3521

PubMed: 29476067 ( click the link to review the publication )

Front Microbiol, 2018, 9:2022

PubMed: 30283406 ( click the link to review the publication )

J Cell Biochem, 2018, 119(5):4193-4204

PubMed: 29274289 ( click the link to review the publication )

Retrovirology, 2018, 15(1):36

PubMed: 29751762 ( click the link to review the publication )

Exp Cell Res, 2018, 371(1):231-237

PubMed: 30107147 ( click the link to review the publication )

BMC Cancer, 2018, 18(1):466

PubMed: 29695239 ( click the link to review the publication )

Oncol Rep, 2018, 39(1):264-270

PubMed: 29115632 ( click the link to review the publication )

Ann Hematol, 2018, 97(5):839-849

PubMed: 29359239 ( click the link to review the publication )

Biochem Biophys Res Commun, 2018, 498(3):481-486

PubMed: 29505792 ( click the link to review the publication )

AAPS PharmSciTech, 2018, 19(2):634-647

PubMed: 28948528 ( click the link to review the publication )

Cell Biochem Funct, 2018, 36(8):398-407

PubMed: 30484863 ( click the link to review the publication )

Alcohol Clin Exp Res, 2018, 42(11):2160-2171

PubMed: 30103280 ( click the link to review the publication )

Sci Adv, 2018, 4(9):eaar4666

PubMed: 30263952 ( click the link to review the publication )

Nat Struct Mol Biol, 2017, 24(1):47-54

PubMed: 27870832 ( click the link to review the publication )

Clin Cancer Res, 2017, 23(12):3139-3149

PubMed: 27986747 ( click the link to review the publication )

Haematologica, 2017, 102(4):736-745

PubMed: 27979926 ( click the link to review the publication )

Clin Cancer Res, 2017, 23(12):3084-3096

PubMed: 27993968 ( click the link to review the publication )

Oncogene, 2017, 36(34):4859-4874

PubMed: 28414307 ( click the link to review the publication )
Oncogene, 2017, 36(12):1707-1720

PubMed: 27694895 ( click the link to review the publication )

Br J Pharmacol, 2017, 174(20):3608-3622

PubMed: 28749535 ( click the link to review the publication )

Eur J Med Chem, 2017, 127:531-553

PubMed: 28109947 ( click the link to review the publication )

Eur J Med Chem, 2017, 141:596-602

PubMed: 29102179 ( click the link to review the publication )

Cancer Sci, 2017, 108(7):1485-1492

PubMed: 28498513 ( click the link to review the publication )

Int J Mol Sci, 2017, 18(5)

PubMed: 28481295 ( click the link to review the publication )

J Biol Chem, 2017, 292(12):5043-5054

PubMed: 28167529 ( click the link to review the publication )

J Pharmacol Exp Ther, 2017, 363(2):211-220

PubMed: 28860353 ( click the link to review the publication )

Pharm Res, 2017, 34(3):668-679

PubMed: 28101809 ( click the link to review the publication )

Cancer Med, 2017, 6(11):2673-2685

PubMed: 29024573 ( click the link to review the publication )

Int J Cell Biol, 2017, 2017:6169310

PubMed: 28321257 ( click the link to review the publication )

Connect Tissue Res, 2017, 58(1):64-75

PubMed: 27404795 ( click the link to review the publication )

Pulm Pharmacol Ther, 2017, 44:88-95

PubMed: 28323055 ( click the link to review the publication )

Am J Surg, 2017, 213(4):645-651

PubMed: 28007318 ( click the link to review the publication )

Oncotarget, 2017, 8(28):45687-45697

PubMed: 28537899 ( click the link to review the publication )

Oncotarget, 2017, 9(1):512-523

PubMed: 29416632 ( click the link to review the publication )

Oncotarget, 2017, 8(31):51429-51446

PubMed: 28881658 ( click the link to review the publication )

CPT Pharmacometrics Syst Pharmacol, 2017, 6(11):756-764

PubMed: 29045072 ( click the link to review the publication )

Sci Rep, 2017, 7(1):2290

PubMed: 28536458 ( click the link to review the publication )

Oncotarget, 2017, 8(45):78480-78495

PubMed: 29108243 ( click the link to review the publication )

JCI Insight, 2017, 2(1):e85811

PubMed: 28097226 ( click the link to review the publication )

JCI Insight, 2017, 2(6):e90196

PubMed: 28352655 ( click the link to review the publication )

Oncotarget, 2017, 10.18632/oncotarget.15017

PubMed: 28157715 ( click the link to review the publication )

Oncotarget, 2017, 8(44):77254-77267

PubMed: 29100385 ( click the link to review the publication )
Cell Host Microbe, 2017, 21(5):569-579

PubMed: 28494238 ( click the link to review the publication )

Ann Oncol, 2016, 27(3):508-13

PubMed: 26658891 ( click the link to review the publication )

Nat Commun, 2016, 7:11363

PubMed: 27193833 ( click the link to review the publication )

Cancer Res, 2016, 76(23):7001-7011

PubMed: 27671680 ( click the link to review the publication )

Cancer Res, 2016, 76(8):2376-83

PubMed: 26941288 ( click the link to review the publication )

Int J Cancer, 2016, 139(1):194-204

PubMed: 26914605 ( click the link to review the publication )

Drug Discov Today, 2016, 21(9):1553-1560

PubMed: 27371506 ( click the link to review the publication )

mBio, 2016, 7(6)

PubMed: 27803184 ( click the link to review the publication )

J Med Chem, 2016, 59(4):1613-33

PubMed: 26681404 ( click the link to review the publication )

Mol Cancer Ther, 2016, 15(6):1364-75

PubMed: 27196750 ( click the link to review the publication )

Mol Cell Proteomics, 2016, 15(6):2076-92

PubMed: 27067055 ( click the link to review the publication )

Neuropharmacology, 2016, 107:111-121

PubMed: 26970016 ( click the link to review the publication )

Biochem Pharmacol, 2016, 102:130-140

PubMed: 26718586 ( click the link to review the publication )

Sci Rep, 2016, 6:38219

PubMed: 27910887 ( click the link to review the publication )

Am J Pathol, 2016, 186(10):2701-8

PubMed: 27555113 ( click the link to review the publication )

J Biol Chem, 2016, 291(19):10131-47

PubMed: 27022024 ( click the link to review the publication )

Neurochem Int, 2016, 96:24-31

PubMed: 27103167 ( click the link to review the publication )

Int J Oncol, 2016, 49(6):2453-2463

PubMed: 27748897 ( click the link to review the publication )

Am J Physiol Heart Circ Physiol, 2016, 311(5):H1139-H1149

PubMed: 27638876 ( click the link to review the publication )

Cancer Biol Ther, 2016, 17(1):27-35

PubMed: 26575826 ( click the link to review the publication )

Anal Bioanal Chem, 2016, 408(13):3547-53

PubMed: 26968571 ( click the link to review the publication )

BMC Cancer, 2016, 16:667

PubMed: 27549189 ( click the link to review the publication )

J Hum Genet, 2016, 10.1038/jhg.2016.61

PubMed: 27251006 ( click the link to review the publication )

Med Oncol, 2016, 33(2):11

PubMed: 26732474 ( click the link to review the publication )
Inflammation, 2016, 39(1):39-46

PubMed: 26228975 ( click the link to review the publication )

PLoS One, 2016, 11(8):e0160826

PubMed: 27536989 ( click the link to review the publication )

PLoS One, 2016, 11(1):e0145985

PubMed: 26726879 ( click the link to review the publication )

Onco Targets Ther, 2016, 9:6843-6855

PubMed: 27877053 ( click the link to review the publication )

Leuk Lymphoma, 2016, 57(3):692-9

PubMed: 26084206 ( click the link to review the publication )

Asian Pac J Trop Med, 2016, 9(6):572-6

PubMed: 27262069 ( click the link to review the publication )

Genet Mol Res, 2016, 15(4)

PubMed: 27819724 ( click the link to review the publication )

Oncotarget, 2016, 8(62):104733-104744

PubMed: 29285209 ( click the link to review the publication )

Oncotarget, 2016, 7(36):58142-58147

PubMed: 27494885 ( click the link to review the publication )

Sci Rep, 2016, 6:21678

PubMed: 26902929 ( click the link to review the publication )

Oncotarget, 2016, 7(6):6727-47

PubMed: 26734995 ( click the link to review the publication )

Nat Commun, 2015, 6:7888

PubMed: 26223951 ( click the link to review the publication )

Nat Commun, 2015, 3;6:10091

PubMed: 26631872 ( click the link to review the publication )

EMBO Mol Med, 2015, 10.15252/emmm.201404396

PubMed: 25872941 ( click the link to review the publication )

EMBO Mol Med, 2015, 10.15252/emmm.201404580

PubMed: 25759362 ( click the link to review the publication )

Clin Cancer Res, 2015, 10.1158/1078-0432.CCR-14-2701

PubMed: 25813020 ( click the link to review the publication )

Clin Cancer Res, 2015, 21(7):1628-38

PubMed: 25623213 ( click the link to review the publication )

Blood Cancer J, 2015, 5:e312

PubMed: 25978432 ( click the link to review the publication )

Int J Cancer, 2015, 136(11):2717-29

PubMed: ( click the link to review the publication )

EBioMedicine, 2015, 3:108-121

PubMed: 26870822 ( click the link to review the publication )

Cancer Lett, 2015, 356(2 Pt B):828-36

PubMed: 25449774 ( click the link to review the publication )

Cancer Lett, 2015, 366(1):32-43

PubMed: 26028172 ( click the link to review the publication )

Breast Cancer Res, 2015, 17:33

PubMed: 25888415 ( click the link to review the publication )

Cell Death Dis, 2015, 6:e1657

PubMed: 25695609 ( click the link to review the publication )
Acta Neuropathol Commun, 2015, 3(1):22

PubMed: 25853389 ( click the link to review the publication )

Endocr Relat Cancer, 2015, 22(5):777-92

PubMed: 26206775 ( click the link to review the publication )

Br J Haematol, 2015, 168(3):371-83

PubMed: ( click the link to review the publication )

Epigenetics, 2015, 10.1080/15592294.2015.1039216

PubMed: 25923331 ( click the link to review the publication )

Am J Cancer Res, 2015, 5(4):1337-52

PubMed: 26101701 ( click the link to review the publication )

Neuropharmacology, 2015, 99:67-78

PubMed: 26188143 ( click the link to review the publication )

Biochemical Pharmacology, 2015, 94(2):79-90

PubMed: ( click the link to review the publication )

Biochem Pharmacol, 2015, 94(2):79-90

PubMed: 25600908 ( click the link to review the publication )

Biochemical Pharmacology, 2015, 94(2):79-90

PubMed: ( click the link to review the publication )

Apoptosis, 2015, 20(7):975-85

PubMed: 25835755 ( click the link to review the publication )

J Biol Chem, 2015, 290(8):5028-40

PubMed: 25540204 ( click the link to review the publication )

J Biol Chem, 2015, 290(39):23725-37

PubMed: 26269591 ( click the link to review the publication )

J Biol Chem, 2015, 290(3):1829-36

PubMed: 25492871 ( click the link to review the publication )

J Biol Chem, 2015, 290(8):5028-40

PubMed: ( click the link to review the publication )

BMC Cancer, 2015, 15(1):273

PubMed: 25880212 ( click the link to review the publication )

FEBS Lett, 2015, 589(10):1080-8

PubMed: 25816750 ( click the link to review the publication )

J Biotechnol, 2015, 10.1016/j.jbiotec.2015.02.029

PubMed: 25746901 ( click the link to review the publication )

Mol Vis, 2015, 21:502-14

PubMed: 25999677 ( click the link to review the publication )

Mol Med Rep, 2015, 12(3):4291-4297

PubMed: 26095064 ( click the link to review the publication )

Oncotarget, 2015, 6(18):15814-27

PubMed: 26158412 ( click the link to review the publication )

Circ Heart Fail, 2015, 8(6):1094-104

PubMed: 26371176 ( click the link to review the publication )

Sci Transl Med, 2014, 6(256):256ra135

PubMed: 25273096 ( click the link to review the publication )

Acta Neuropathol, 2014, 128(2):291-303

PubMed: 24839957 ( click the link to review the publication )

Nat Commun, 2014, 5:3361

PubMed: 24553445 ( click the link to review the publication )
Clin Cancer Res, 2014, 10.1158/1078-0432.CCR-14-0384

PubMed: 25355930 ( click the link to review the publication )

Int J Cancer, 2014, 135(7):1721-32

PubMed: 24615207 ( click the link to review the publication )

Diabetes, 2014, 63(9):2924-34

PubMed: 24722245 ( click the link to review the publication )

Oncogene, 2014, 33(25):3307-15

PubMed: 23995789 ( click the link to review the publication )

Cancer Lett, 2014, 10.1016/j.canlet.2014.10.034

PubMed: ( click the link to review the publication )

Cancer Lett, 2014, 351(1):50-8

PubMed: 24814395 ( click the link to review the publication )

PLoS Pathog, 2014, 10(4):e1004071

PubMed: 24722454 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1134

PubMed: 24651437 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1177

PubMed: 24743732 ( click the link to review the publication )

Mol Cancer Ther, 2014, 13(12):2784-92

PubMed: 25319394 ( click the link to review the publication )

J Mol Biol, 2014, 426(20):3442-53

PubMed: 24657767 ( click the link to review the publication )

Hum Gene Ther, 2014, 25(7):599-608

PubMed: 24568341 ( click the link to review the publication )

J Biol Chem, 2014, 289(14):9918-25

PubMed: 24515107 ( click the link to review the publication )

Cancer Cell Int, 2014, 10.1186/s12935-014-0112-x

PubMed: ( click the link to review the publication )

Cancer Cell Int, 2014, 14(1):112

PubMed: 25546354 ( click the link to review the publication )

Mol Cell Biol, 2014, 34(7):1280-9

PubMed: 24469401 ( click the link to review the publication )

Proteomics Clin Appl, 2014, 8(11-12):924-31

PubMed: 25091122 ( click the link to review the publication )

J Alzheimers Dis, 2014, 41(4):1193-205

PubMed: 24844691 ( click the link to review the publication )

Virology, 2014, 462-463:328-39

PubMed: 25014309 ( click the link to review the publication )

Cancer Biol Ther, 2014, 15(5):578-85

PubMed: 24556916 ( click the link to review the publication )

BMC Cancer, 2014, 14(1):373

PubMed: 24886166 ( click the link to review the publication )

FEBS Lett, 2014, 588(9):1571-9

PubMed: 24607544 ( click the link to review the publication )

Mol Med Rep, 2014, 10(5):2729-35

PubMed: 25199623 ( click the link to review the publication )

Oncol Lett, 2014, 7(5):1673-1678

PubMed: 24765199 ( click the link to review the publication )
Pharmacol Res Perspect, 2014, 2(3):e00043

PubMed: 25505589 ( click the link to review the publication )

Head Neck, 2014, 10.1002/hed.23822.

PubMed: 24986420 ( click the link to review the publication )

Cytometry A, 2014, 85(1):78-87

PubMed: 24038859 ( click the link to review the publication )

Curr Pharm Desigh, 2014, 20(11):1874-80

PubMed: 23888956 ( click the link to review the publication )

Pharmacology Research Perspectives, 2014, 10.1002/prp2.43

PubMed: ( click the link to review the publication )

Oncotarget, 2014, 5(15):5965-77

PubMed: 25115389 ( click the link to review the publication )

Blood, 2013, 14;121(11):2038-50

PubMed: 23327920 ( click the link to review the publication )

Blood, 2013, 123(5):706-16

PubMed: 24319254 ( click the link to review the publication )

Nat Struct Mol Biol, 2013, 20(3):317-25

PubMed: 23377543 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2013, 111(3):E364-73

PubMed: 24395801 ( click the link to review the publication )

PLoS Biol, 2013, 12(1):e1001758

PubMed: 24409098 ( click the link to review the publication )

Cancer Res, 2013, 73(8):2428-34

PubMed: 23382048 ( click the link to review the publication )

Cell Rep, 2013, 5(6):1679-89

PubMed: 24360956 ( click the link to review the publication )

Int J Cancer, 2013, 132(9):2200-8

PubMed: 23024001 ( click the link to review the publication )

Neuropsychopharmacology, 2013, 38(9):1674-84

PubMed: 23474591 ( click the link to review the publication )

Oncogene, 2013, 33(33):4265-72

PubMed: 24292675 ( click the link to review the publication )

Oncogene, 2013, 32(10):1316-29

PubMed: 22543582 ( click the link to review the publication )

Cell Death Dis, 2013, 4:e733

PubMed: 23868066 ( click the link to review the publication )

Cell Death Dis, 2013, 4:e951

PubMed: 24309938 ( click the link to review the publication )

Br J Haematol, 2013, 160(2):188-98

PubMed: 23167276 ( click the link to review the publication )

AIDS, 2013, 27(18):2853-62

PubMed: 24189584 ( click the link to review the publication )

J Biol Chem, 2013, 288(35):25593-602

PubMed: 23878197 ( click the link to review the publication )

J Biol Chem, 2013, 288(20):14400-7

PubMed: 23539624 ( click the link to review the publication )

PLoS Comput Biol, 2013, 9(2):e1002887

PubMed: 23408876 ( click the link to review the publication )
Mol Carcinog, 2013, 52(3):218-28

PubMed: 22121107 ( click the link to review the publication )

Front Pharmacol, 2013, 4:44

PubMed: 23596417 ( click the link to review the publication )

Genes Brain Behav, 2013, 13(1):69-86

PubMed: 24286462 ( click the link to review the publication )

Cell Cycle, 2013, 12(13):2073-83

PubMed: 23759592 ( click the link to review the publication )

PLoS One, 2013, 8(6):e66130

PubMed: 23762475 ( click the link to review the publication )

PLoS One, 2013, 8(1):e53766

PubMed: 23320102 ( click the link to review the publication )

J Thromb Thrombolysis, 2013, 35(2):185-92

PubMed: 23229086 ( click the link to review the publication )

Cell Death Dis, 2013, 4:e655

PubMed: 23744355 ( click the link to review the publication )

Blood, 2012, 8;120(19):3958-67

PubMed: 22983447 ( click the link to review the publication )

J Exp Med, 2012, 209(1):35-50

PubMed: 22231305 ( click the link to review the publication )

Clin Cancer Res, 2012, 18(14):3822-33

PubMed: 22623731 ( click the link to review the publication )

Clin Cancer Res, 2012, 18(2):408-16

PubMed: 22038994 ( click the link to review the publication )

Cancer Res, 2012, 72(9):2251-61

PubMed: 22422937 ( click the link to review the publication )

Cell Death Differ, 2012, 19(12):2029-39

PubMed: 22858545 ( click the link to review the publication )

Cell Death Differ, 2012, 19(8):1317-27

PubMed: 22322857 ( click the link to review the publication )

Eur J Cancer, 2012, 48(7):1096-107

PubMed: 22154545 ( click the link to review the publication )

Diabetologia, 2012, 55(9):2421-31

PubMed: 22772764 ( click the link to review the publication )

FASEB J, 2012, 26(7):3032-41

PubMed: 22459148 ( click the link to review the publication )

J Neurochem, 2012, 123 Suppl 2:108-15

PubMed: 23050648 ( click the link to review the publication )

J Leukoc Biol, 2012, 91(5):701-9

PubMed: 22028329 ( click the link to review the publication )

J Biol Chem, 2012, 287(43):36609

PubMed: 22952229 ( click the link to review the publication )

Mol Carcinog, 2012, 52(6):459-74

PubMed: 22308110 ( click the link to review the publication )

Invest New Drugs, 2012, 30(2):541-7

PubMed: 21107885 ( click the link to review the publication )

Pharm Res, 2012, 29(7):1960-76

PubMed: 22415140 ( click the link to review the publication )
Oncol Rep, 2012, 28(1):105-10

PubMed: 22484732 ( click the link to review the publication )

PLoS One, 2012, 7(9):e44265

PubMed: 22957056 ( click the link to review the publication )

PLoS One, 2012, 7(12):e52335

PubMed: 23272238 ( click the link to review the publication )

PLoS One, 2012, 7(12):e52753

PubMed: 23300762 ( click the link to review the publication )

Chronobiol Int, 2012, 29(8):982-93

PubMed: 22891617 ( click the link to review the publication )

Biochem Biophys Res Co, 2012, 420(2):325-30

PubMed: 22425986 ( click the link to review the publication )

Pediatr Surg Int, 2012, 28(6):579-89

PubMed: 22526548 ( click the link to review the publication )

Protein Expr Purif, 2012, 86(1):45-52

PubMed: 21992606 ( click the link to review the publication )

Brain, 2011, 134(Pt 8):2408-21

PubMed: 21772061 ( click the link to review the publication )

Clin Cancer Res, 2011, 17(9):2819-29

PubMed: 21357681 ( click the link to review the publication )

Clin Cancer Res, 2011, 17(16):5311-21

PubMed: 21724551 ( click the link to review the publication )

Genes Dev, 2011, 25(24):2610-8

PubMed: 22016339 ( click the link to review the publication )

J Neurosci, 2011, 31(11):3990-9

PubMed: 21411642 ( click the link to review the publication )

J Transl Med, 2011, 9:37

PubMed: 21477288 ( click the link to review the publication )

Retrovirology, 2011, 2(3):411-23

PubMed: 21966324 ( click the link to review the publication )

Mol Med, 2011, 17(5-6):466-72

PubMed: 21424110 ( click the link to review the publication )

PLoS One, 2011, 6(7):e22739

PubMed: 21818379 ( click the link to review the publication )

BMC Neurosci, 2011, 12:50

PubMed: 21615950 ( click the link to review the publication )

Sci Signal, 2010, 3(146):ra80

PubMed: 21045206 ( click the link to review the publication )

J Pharmacol Exp Ther, 2010, 86(16):8765-72

PubMed: 20739454 ( click the link to review the publication )

Exp Dermatol, 2010, 19(12):1096-102

PubMed: 20629733 ( click the link to review the publication )

产品安全说明书

HDAC抑制剂选择性比较

生物活性

产品描述

Vorinostat (suberoylanilide hydroxamic acid, SAHA)是一种HDAC抑制剂，无细胞试验中IC50为~10 nM。Vorinostat 会抑制高效的HPV-18 DNA扩增。

特性

Vorinostat是广谱HDAC活性抑制剂，抑制I和II类酶。

靶点

HDAC ^[1]
(Cell-free assay)

~10 nM

体外研究

Vorinostat是小分子量（<300）线性肟酸，抑制HDAC活性，包括乙酰化组蛋白和非组蛋白的积累，抑制培养细胞的增殖，且抑制肿瘤生长。Vorinostat通过结合到酶的活性位点而抑制 HDAC活性。Vorinostat 抑制多种转化细胞增殖（包括淋巴瘤，多发性骨髓瘤，白血病，和非小细胞肺癌），与对照组相比抑制生长达50% 时的浓度为0.5 到10μM。Vorinostat作用于淋巴瘤和白血病细胞，包括 Burkitt, B-细胞急性淋巴细胞白血病 (B-ALL), MCL, DLBCL, ATL和T-细胞，不同程度抑制细胞增殖。除了抑制转化细胞增殖, Vorinostat 也抑制正常细胞增殖，通过比较Vorinostat 作用于一组细胞系–正常人非纤维细胞(WI-38)和 SV40巨大T抗原转化WI-38(VA-13细胞)而得到证明。Vorinostat 抑制两种类型细胞增殖，这种作用存在剂量依赖性。但发现Vorinostat 对转化细胞具有选择毒性，包括使肿瘤细胞死亡，而对正常细胞只起抑制作用，不会使其死亡。^[1] Genistein 和Vorinostat 联用效果比5-aza和Vorinostat 联用作用于诱导细胞死亡有效很多。Genistein和Vorinostat联用作用于ARCaP-E使增殖降低 80 %，作用于ARCaP-M细胞，增殖降低60 %以上。Genistein和Vorinostat 联用抑制细胞增殖具有协同效应。作用于ARCaP-E 细胞(820个基因诱导和1046个基因抑制) ARCaP-M 细胞，Vorinostat比Genistein 影响更多基因。^[2] Vorinostat作用于肿瘤细胞表面，提高Fas蛋白水平，这种作用存在剂量依赖性，且按0.75 μM剂量处理，提高达到一个稳定水平。^[3] Vorinostat 抑制肿瘤细胞生长，包括NB4, H460 和HCT-116，IC50分别为0.7μM, 3.4μM和1.2 μM。^[4]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID
A20	NWjaSWdTU2mwYYPlJGF{e2G7		Mo\rNUBp	MXTEUXNQ	NV7qO2Zw[W62aT3ISGFEOSCjY4Tpeol1gSC5aYToJGlEPTBib3[gNE4yOTJizszN	M37KTVEyQTZyNEi5
Friend leukemic cell	M1fRXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Ml31OVAh\|ryP	MX:3NkBp	MnzPSG1UVw>?	M3rr[GlEPTB;MD65PUDPxE1?	NV3JZ21POTJzMEm5NVM>
K562	MX7LbY5ie2ViQYPzZZk>		M{XkdVYhcA>?	NVHRd5RLTE2VTx?=	M3PXeWlvcGmkaYTpc44hd2ZiaIXtZY4hcGm\|dH;u[UBl\WGlZYT5cIF{\SBqbXn4eJVz\SCxZjDISGFEOSCjbnSgTGRCSzJrIIfpeIghUUN3MDDv[kAxNjBzIN88US=>	Mk\6NVI1OTl\|OEC=
HT1080	NX7wOmV4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYW3NkBp	MnTYSG1UVw>?	M3vOV2lEPTB;Mj60JO69VQ>?	Mm\wNVIzPzBzN{W=
H1299	NVX2cXlqU2mwYYPlJGF{e2G7		MmHSNlAhdWmw	NXviNI13TE2VTx?=	MWfJcohq[mm2b4L5JIFkfGm4aYT5JIFo[Wmwc4SgTGRCSyCnbor5cYUhf2m2aDDJR\|UxKG:oIECuNVk1KM7:TR?=	MWSxOFUzOTR{Mh?=
H1299	NInaRoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NX;0bnRKPzJiaB?=	MWLEUXNQ	NEjIdmtKSzVyPUeuNlQh\|ryP	NGi1dZgyPDV{MUSyNi=>
HeLa	NH\3ZXNMcW6jc3WgRZN{[Xl?		NHfqeXo{OCCvaX6=		M2e4bGlvcGmkaYTvdpkh[2:wY3XueJJifGmxbjDh[4FqdnO2IHjpd5RwdmViZHXhZ4V1gWyjc3Wge4l1cCCLQ{WwJI9nKDBwMkig{txO	MVyxOVYxOzl2OR?=
LOX-IMVI	NHXHPXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NIXGRnc1QCCq		M4DxNGlEPTB;MT6zJO69VQ>?	MVqxOVcyPTR5MB?=
NCI-H226	M3vVS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NF3IVWE1QCCq		M3LvdmlEPTB;Mj62JO69VQ>?	NIfiUYsyPTdzNUS3NC=>
RXF-631L	NUjBcZBlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXTObJVKPDhiaB?=		NVzm[4I3UUN3ME2yJO69VQ>?	M{nMe\|E2PzF3NEew
SNB-78	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NVTJUXJoPDhiaB?=		NFPybGxKSzVyPUG2JO69VQ>?	MlXONVU4OTV2N{C=
St-4	NWTiW4VYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MWO0PEBp		M3rFemlEPTB;NT6yJO69VQ>?	MUGxOVcyPTR5MB?=
ARP1	M1vidmZ2dmO2aX;uJGF{e2G7	MmrnNkDPxE1?	MV62JIg>		MW\JcoR2[3Srb36gc4YhWDJzV1HGNUBo\W6nIHX4dJJme3Orb36=	NYLqRnBpOTR5M{S4NFY>
CEM	M{XRZWtqdmG\|ZTDBd5NigQ>?		M3\NW\|EhcA>?	MXLEUXNQ	MoW2TY5pcWKrdHnvckBw\iCKRFHDJJdqfGhiSVO1NEBw\iByLkOzJO69VQ>?	NX;s[ItzOTZ2MkCwOlQ>
HCT15	MnntS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NGrXSHA1QCCq		M{HSemdKPTB;MD64NkDPxE1?	M2T3TlE3PzJ\|MkK3
NCI-H23	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NF3aNoM1QCCq		NWWxTZZ[T0l3ME2wMlkzKM7:TR?=	MofNNVY4OjN{Mke=
GM15850	Mo\mT4lv[XOnIFHzd4F6	MV6yMlUh\|ryP	MmfUPVYhcA>?	MmXsSG1UVw>?	MkPlTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIHjpd5RwdmViSEOgcJl{cW6nIEG0JIFk\XS7bHH0bY9vKG:oIF\YUkBo\W6n	M4fCOFE3QTJzM{[3
GM15850	M3z3bGtqdmG\|ZTDBd5NigQ>?	M3Pj[\|IvPSEQvF2=	NWe4[5NIQTZiaB?=	MlrwSG1UVw>?	NFfMdVlKdmirYnn0bY9vKG:oIFjERWMh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIOEBtgXOrbnWgOUBi[2W2eXzheIlwdiCxZjDGXG4h\2WwZR?=	Mm\HNVY6OjF\|Nke=
GM15850	MnnxT4lv[XOnIFHzd4F6	MkLRNk42KM7:TR?=	Mo\QPVYhcA>?	M125cmROW09?	M1vSWmlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDobZN1d26nIFi0JIx6e2mwZTCxNkBi[2W2eXzheIlwdiCxZjDGXG4h\2WwZR?=	MoLHNVY6OjF\|Nke=
GM15850	Ml3OT4lv[XOnIFHzd4F6	M2nsTlIvPSEQvF2=	NF:wbYk6PiCq	NIK0SWpFVVOR	MVXJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCKMzDsfZNqdmViOTDhZ4V1gWyjdHnvckBw\iCIWF6g[4Vv\Q>?	NFXo[YkyPjl{MUO2Oy=>
GM15850	MkP0T4lv[XOnIFHzd4F6	NEL2e5MzNjVizszN	NVzw[Y9NQTZiaB?=	MUHEUXNQ	MlfZTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIHjpd5RwdmViSESgcJl{cW6nIEigZYNmfHmuYYTpc44hd2ZiRmjOJIdmdmV?	NF;oVIIyPjl{MUO2Oy=>
GM15850	NVS3NFd6U2mwYYPlJGF{e2G7	MWiyMlUh\|ryP	NXnBOG9oQTZiaB?=	Mm\BSG1UVw>?	MWjJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCKNDDsfZNqdmViMU[gZYNmfHmuYYTpc44hd2ZiRmjOJIdmdmV?	MoX3NVY6OjF\|Nke=
U937	MXHGeY5kfGmxbjDBd5NigQ>?	MonCOUDPxE1?	NXSxbYFpOjRiaB?=	M3jEbWROW09?	NGnS[2tE\WyuIHP5Z4xmKGG{cnXzeEBjgSCjY3P1cZVt[XSrb36gZZQhWy:JMj;NJJBp[XOn	M2\o[\|E4ODB2N{G4
H661	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MYq0PEBp		Mn[wTWM2OD1zIN88US=>	MVOxO\|E2PzByOR?=
U937	MkfrSpVv[3Srb36gRZN{[Xl?	MlrZOUDPxE1?	M3;ub\|I1KGh?	MUXEUXNQ	NE\wPYZKdmO{ZXHz[UBqdiCqaYP0c45mKEh\|IHHj[ZR6dGG2aX;u	M3zoW\|E4PDR5N{Ww
U937	NIm0b4NHfW6ldHnvckBCe3OjeR?=	Mm\YNUDPxE1?	MVmyOEBp	M2LFcGROW09?	M13RUGVn\mWldDDvckBidHCqYTD0eYJ2dGmwIHHj[ZR6dGG2aX;u	NXrEOG8zOTd2NEe3OVA>
RAW264.7	NX7SclBjTnWwY4Tpc44hSXO\|YYm=	MXmxNEDPxE1?	NXHlSYxnOjSq	NGDafZV4[XSnch?=	NVjsU4hkUW6qaXLpeIlwdiCxZjDMVHMue3SrbYXsZZRm\CCWTl\hcJBp[SCycn;keYN1cW:wIIfpeIghUUN3MDDv[kAxNjd4IN88US=>	M4HtPFE4PDd5NUG4
RAW264.7	NEDRPIJHfW6ldHnvckBCe3OjeR?=	Mn3vNVAh\|ryP	NIHQXFgzPGh?	NVLPfYRHf2G2ZYK=	NWTSR2tIUW6qaXLpeIlwdiCxZjDMVHMue3SrbYXsZZRm\CCQTzDwdo9lfWO2aX;uJJdqfGhiSVO1NEBw\iBzLki4JO69VQ>?	NGDCcFQyPzR5N{WxPC=>
SC9	NETmUXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MUe0PEBp		M{T2N2lEPTB;MD62NFYh\|ryP	NXHDdZl3OTd3MEeyNVk>
ST14A	M3PoWWZ2dmO2aX;uJGF{e2G7	MWW1JI5O	M3L1WFczKGh?		NFPacJZKdmO{ZXHz[UBqdiCURWPUM25TW0ZibWLORUBmgHC{ZYPzbY9v	NYHOeZI2OTd3NkW5PVM>
ST14A	MVvGeY5kfGmxbjDBd5NigQ>?	NITqbpM2KG6P	M{f1blczKGh?		MXXJcoNz\WG\|ZTDpckBGOkZzIH3SUmEh\XiycnXzd4lwdg>?	MmPFNVc2PjV7OUO=
PANC1	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NInLenkyKM7:TR?=			NX\oUmFFUUN3ME2wMlQ2KM7:TR?=	M1jzRVE4PTh6N{S0
PANC1	NWO4NW1qTnWwY4Tpc44hSXO\|YYm=	Mo[4NUDPxE1?	NG\TU2wzPCCq		M1LMXmlv[3KnYYPlJIlvKHB{MWfBSlEwS0mSMTDn[Y5mKGW6cILld5Nqd25?	NWD2eIEyOTd3OEi3OFQ>
PANC1	MWjGeY5kfGmxbjDBd5NigQ>?	NWLnOYV2OSEQvF2=	NILqR5YzPCCq		NX3xc3BkUW6lcnXhd4UhcW5icEK3b4lxOSCpZX7lJIV5eHKnc4Ppc44>	MnPmNVc2QDh5NES=
PT45	NEjvXZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3T1NmlEPTB;NDFOwG0>	M2flcVE4PTh6N{S0
ACHN	MnHyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4DCVFIyKGh?		MojNS2k2OD1yLk[1JO69VQ>?	M1L2VlE4PjZ{NkC2
PC3	MoDPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MUWyNUBp		MUnHTVUxRTBwN{Gg{txO	MXuxO\|Y3OjZyNh?=
A431	NFKzO\|lEgXSxdH;4bYMhSXO\|YYm=		NUTxWlhZPzJiaB?=		MUPJR\|UxRTRwMjFOwG0>	M33tV\|E4PjlzN{[z
Cal27	NVXvPYNpS3m2b4TvfIlkKEG\|c3H5		NHXVbng4OiCq		NHTOUYtKSzVyPUOuNkDPxE1?	NITkXlYyPzZ7MUe2Ny=>
CCRF-CEM	MlS0R5l1d3SxeHnjJGF{e2G7		NVv5UIZGPzJiaB?=		MofXTWM2OD1yLkig{txO	NIW5OmYyPzZ7MUe2Ny=>
EOL1	NHfBT5VEgXSxdH;4bYMhSXO\|YYm=		NIPIV444OiCq		MYfJR\|UxRTFizszN	MmjRNVc3QTF5NkO=
Hec-1-A	NHnQUJFEgXSxdH;4bYMhSXO\|YYm=		NX7aSpZKPzJiaB?=		MXvJR\|UxRTFizszN	NGWzbFkyPzZ7MUe2Ny=>
HeLa	MX;LbY5ie2ViQYPzZZk>	NH3SR5gyOCEQvF2=	MW[zNEBucW5?	MWjEUXNQ	NFPPU21KdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JGhFSUNzIIfpeIghUUN3MDDv[kAxNjB{IN88US=>	MVqxO\|Y6OTd4Mx?=
RKOp21	M4fKdWN6fG:2b4jpZ{BCe3OjeR?=		NXryVXY{PzJiaB?=		NUe1ZoVxUUN3ME2xMlc3KM7:TR?=	NFjQZYsyPzZ7MUe2Ny=>
Saos2	MUnDfZRwfG:6aXOgRZN{[Xl?		NG\qSnk4OiCq		M3rMZmlEPTB;Mj6zJO69VQ>?	MWqxO\|Y6OTd4Mx?=
SK-OV-3	MUTDfZRwfG:6aXOgRZN{[Xl?		NVu2dXgxPzJiaB?=		MmDHTWM2OD1{LkKg{txO	MkjUNVc3QTF5NkO=
U87MG	NWS1Om5wS3m2b4TvfIlkKEG\|c3H5		MnvmO\|IhcA>?		NXW4U484UUN3ME2xNUDPxE1?	NFu0PHQyPzZ7MUe2Ny=>
NUGC3	M3TON2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MXG1JO69VQ>?	M4D2UFI1KGh?		MknkS2k2OD1{Lke5JO69VQ>?	NUj6N5QzOTd7MES4OFM>
CCD1059SK	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVzJR\|UxRTR\|LkWg{txO	NUHyZpUyOTh{NEe1OVQ>
HepG2	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2jjeWlEPTB;MD6wNFA3KM7:TR?=	MnrJNVgzPDd3NUS=
HT1080	NIPncYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXH0UFBSUUN3ME2wMlAxOjRizszN	M4XrfFE5OjR5NUW0
SKBR3	M3PtT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIXwTnBKSzVyPUCuPEDPxE1?	NV\DR5JuOTh{NEe1OVQ>
SNB78	NXjZNnVsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4HoUGVEPTB;MU[g{txO	M3nSdFE5OjR5NUW0
SQ20B	NFvhVIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1XrOGlEPTB;MzFOwG0>	MWixPFI1PzV3NB?=
St4	M1TtN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGL2ZmVGSzVyPUWuNkDPxE1?	M334dVE5OjR5NUW0
MCF7	MorUSpVv[3Srb36gRZN{[Xl?	NIPnXGEyOCEQvF2=	MoTqPEBp	NUPFTZc5TE2VTx?=	M{DCT2lv\HWldHnvckBw\iC2dXL1cIlvKGi7cHXyZYNmfHmuYYTpc44>	NUW3R2k{OTh{NkmyNlY>
HEK293	NE\GbppMcW6jc3WgRZN{[Xl?		MliyNUBp	Moj0SG1UVw>?	MVvJcohq[mm2aX;uJI9nKEiGQVOxJJdqfGhiSVO1NEBw\iByLkCzJO69VQ>?	M2fpU\|E5OzB6NU[z
HEK293	NWHMS3BFU2mwYYPlJGF{e2G7		M2TLRlEhcA>?	NXmx[XM2TE2VTx?=	MnXvTY5pcWKrdHnvckBw\iCKRFHDN{B4cXSqIFnDOVAhd2ZiMD6wOVch\|ryP	NFSze\|MyQDNyOEW2Ny=>
G401	MlfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWP3WXdnPzJiaB?=	NVrxfoQzTE2VTx?=	MkDaTWM2OD1zIN88US=>	NWTUVGNLOTh\|N{CzO\|M>
HeLa	MoTVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MnfzO\|IhcA>?	NHTwSmhFVVOR	NYnYR\|JwUUN3ME2wMlQ3KM7:TR?=	MVexPFM4ODN5Mx?=
Human renal epithelial cell	Mk\TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MlnkO\|IhcA>?	MXTEUXNQ	NIOxWWdKSzVyPUG0JO69VQ>?	MX2xPFM4ODN5Mx?=
U937	MUfGeY5kfGmxbjDBd5NigQ>?	MVG1JO69VQ>?	MVKyOEBp		M3THb2lv\HWldHnvckBw\iCqaYP0c45mKEh2IHj5dIVz[WOndInsZZRqd25?	NF\6UY4yQDN6MUKzPC=>
U937	M3nO[2Z2dmO2aX;uJGF{e2G7	MXW1JO69VQ>?	NE[yNXozPCCq		Ml\tTY5lfWO2aX;uJI9nKGGucHjhJJR2[nWuaX6gbJlx\XKjY3X0fYxifGmxbh?=	M2e2PFE5OzhzMkO4
U937	Ml3xSpVv[3Srb36gRZN{[Xl?	M4jhb\|Uh\|ryP	MVuyOEBp		M1PF[Glv\HWldHnvckBw\iCyMkGg[ZhxemW\|c3nvci=>	MmfvNVg{QDF{M{i=
U937	MlXrSpVv[3Srb36gRZN{[Xl?	NEXNbIM2KM7:TR?=	MX[yOEBp		MXXJcoR2[3Srb36gc4Yh[XCxcITvd4l{	MX2xPFM5OTJ\|OB?=
U937	NYnZdZpZTnWwY4Tpc44hSXO\|YYm=	NF\kOXU2KM7:TR?=	MV2yOEBp		M4Daemlv\HWldHnvckBw\iCpcnHueYxw[3m2aXOg[Iln\mW{ZX70bYF1cW:w	NVrvXYRqOTh\|OEGyN\|g>
U937	NYHkdmxuU2mwYYPlJGF{e2G7	NGezO442KM7:TR?=	M2Tyd\|I1KGh?		NXTHVIRoUW6qaXLpeIlwdiCxZjDoeY1idiCKRFHDNS=>	NHjzWXEyQDN6MUKzPC=>
U937	Mn65T4lv[XOnIFHzd4F6	M{XiZlUh\|ryP	Mle3NlQhcA>?		NEDsfZlKdmirYnn0bY9vKG:oIHj1cYFvKEiGQVO0	M3LlWFE5OzhzMkO4
HEK-TE	NXX2OoduTnWwY4Tpc44hSXO\|YYm=	M3TVZVUh\|ryP	MWW2bC=>	NE\sRpJFVVOR	MYXJcoNz\WG\|ZTDpckBpcXO2b37lJGg{KGGlZYT5cIF1cW:w	MWCxPFQ{PDF2NB?=
HPDE6c7	MmDHR5l1d3SxeHnjJGF{e2G7	MUK1NEDPxE1?	MlrWO\|IhcA>?	M4jXOmROW09?	MnK3TWM2OD1zLkOg{txO	MVGxPFQ6PDR4Mx?=
Human microvascular epithelial cell	MWTDfZRwfG:6aXOgRZN{[Xl?	NHjGSVk2OCEQvF2=	MWG3NkBp	MkD0SG1UVw>?	NHLMdG1KSzVyPUGuN{DPxE1?	MVWxPFQ6PDR4Mx?=
Hup T3	NULPUVFJS3m2b4TvfIlkKEG\|c3H5	MmDKOVAh\|ryP	M1;HTVczcA>?	M{fSTWROW09?	M4PZfGlEPTB;MD64JO69VQ>?	NXHCOY5{OTh2OUS0OlM>
Mia Paca2	M1jaSGN6fG:2b4jpZ{BCe3OjeR?=	NILPOlU2OCEQvF2=	MUS3Nog>	Mn;2SG1UVw>?	M3rQUWlEPTB;MT6xJO69VQ>?	NFjLT2EyQDR7NES2Ny=>
Panc 04.03	MXLDfZRwfG:6aXOgRZN{[Xl?	MmrjOVAh\|ryP	NGHneY44Omh?	M1v0NGROW09?	NUS0UIhbUUN3ME2xMlIh\|ryP	M3\hVFE5PDl2NE[z
SU 86.86	MnnYR5l1d3SxeHnjJGF{e2G7	MoKwOVAh\|ryP	NVrNZoFZPzKq	NYrvbGRZTE2VTx?=	NELtdo1KSzVyPUGuN{DPxE1?	NHvkWnYyQDR7NES2Ny=>
HEK293	NGD4Uo5McW6jc3WgRZN{[Xl?		M{n1NVMhcA>?		NWn3VpAzUW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBJTEGFNjDlfJBz\XO\|aX;uJJdqfGhiSVO1NEBw\iByLkCxPUDPxE1?	NXr6VWNROTh3NUi2Olk>
HeLa	NV;vTII3U2mwYYPlJGF{e2G7		MlLmNkBp		MkHTTY5pcWKrdHnvckBw\iCwdXPs[YFzKEiGQVOge4l1cCCLQ{WwJI9nKDBwMEizJO69VQ>?	M1[zR\|E5PTV6Nk[5
RAW264.7	MXvGeY5kfGmxbjDBd5NigQ>?	MUSyJO69VQ>?	NVvuOHZ6Oy53IHi=	NHTNW2FFVVOR	NHXXNGxCdnSrbXHsZZJq[WxiYXP0bZZqfHliYXfhbY5{fCCSbHHzcY9lcXWvIH\hcINqeGG{dX2gbY5n\WO2ZXSge4l1cCCLQ{WwJI9nKDBwMUGg{txO	MmDONVg3PDR7Nkm=
NB4			MWO0PIg>	M1GwcWROW09?	MVvJR\|UxRTBwNjFOwG0>	NUDuRVRnOTh5MkOzOFk>
HEK293	MX;GeY5kfGmxbjDBd5NigQ>?	NUD3bWxPOTBizszN	NX3ndmpIOjRiaB?=	MmLDSG1UVw>?	NYLZe4NiSWO2aY\heIlwdiCxZjDtc5V{\SCZboSzZUB{cWewYXzpcoch\XiycnXzd4Vl	MYCxPVAzOjZ5NR?=
HCT116	M37BWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NYjGN25NPzKq	M4TFT2ROW09?	M2fvOGlEPTB;MD6zNUDPxE1?	M4XJdlE6ODh2Mkm0
HeLa	Ml7YT4lv[XOnIFHzd4F6	NWqxUJVMOiEQvF2=	NILjNWs{OCCvaX6=	Mk[xSG1UVw>?	NEixT4xKdmirYnn0bY9vKG:oIFjERWMzKGmwIHj1cYFvKEinTHGgZ4VtdHNid3n0bEBKSzVyIH;mJFAvOSEQvF2=	M4j6OFE6ODh2Mkm0
IGROV1	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MYe3NkBp	NHXa[WRFVVOR	NFHZUIJKSzVyPUKuNkDPxE1?	MlPLNVkxQDR{OUS=
IGROV1	NWXoZ\|RGU2mwYYPlJGF{e2G7	NYnGcppJPSEQvF2=	NWjqbHdSOjRiaB?=	NGXFbZhFVVOR	M1PpO2lvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCyNUOgZYNmfHmuYYTpc44>	MXOxPVA5PDJ7NB?=
IGROV1	MlX4T4lv[XOnIFHzd4F6	NXK2WJlROTBizszN	NX;kUlNJPCCq	NXnYUo51TE2VTx?=	M2e3fWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCqaYP0c45mNUh2IHHj[ZR6dGG2aX;u	NFPPb5UyQTB6NEK5OC=>
IGROV1	M4SzbWtqdmG\|ZTDBd5NigQ>?	NVS0c\|g5OTBizszN	M3rBT\|QhcA>?	MXHEUXNQ	NV\HW4JoUW6qaXLpeIlwdiCxZjDISGFEPiCjc4Pld5Nm\CCjczDhcJBp[S22dXL1cIlvKGGlZYT5cIF1cW:w	NYT1fmxzOTlyOESyPVQ>
T24	MmnWT4lv[XOnIFHzd4F6		MkS2N{Bp		NH;1SpJKdmS3Y4Tpc44hd2ZiaHnzeI9v\SCKMzDhZ4V1gWyjdHnvckB4cXSqIFXDOVAhd2ZiMD6xNkDPxE1?	MWmxPVA5PDN7NR?=
T24	MYLLbY5ie2ViQYPzZZk>		NUD5Xmd3OyCq		M{jtb2lv\HWldHnvckBw\iCjbIDoZUB1fWK3bHnuJIFk\XS7bHH0bY9vKHerdHigSWM2OCCxZjCwMlI2KM7:TR?=	M3fpbVE6ODh2M{m1
HeLa	NF7DOpVMcW6jc3WgRZN{[Xl?		NF3lfHEyPSCvaX6=	NIDEUlhFVVOR	NFvwW2NKdmirYnn0bY9vKG:oIFjERWM3KG[{b32gcpVkdGWjcjDlfJRz[WO2IIfpeIghUUN3MDDv[kAxNjB6NUWg{txO	Mly4NVkxQTN6OES=
HeLa	MkfqT4lv[XOnIFHzd4F6		NYn5cJlkOTVibXnu	MYDEUXNQ	MVrJcohq[mm2aX;uJI9nKEiGQVO4JIZzd21iboXjcIVieiCneITyZYN1KHerdHigTWM2OCCxZjCxMlg3KM7:TR?=	Mn3FNVkxQTN6OES=
NCI-H69	MlXLR5l1d3SxeHnjJGF{e2G7		NHnpNWM4OiCq	NUmzTWVDTE2VTx?=	M4DCO2lEPTB;Mj6wOkDPxE1?	MoPtNVkxQTN6OES=
SKMES1	NYHibnNMS3m2b4TvfIlkKEG\|c3H5		NWj6NJB4PzJiaB?=	NGW5OVdFVVOR	MW\JR\|UxRTJwNEKg{txO	Mmr2NVkxQTN6OES=
S2	M1LqOmtqdmG\|ZTDBd5NigQ>?	Mn3GNE4yNTFyIN88US=>	MnfRNUBp		NVXENGxYUW6qaXLpeIlwdiCxZjDQcIF{dW:maYXtJIZidGOrcHHyeY0hUESDQ{Gg[ZhxemW\|c3XkJJdqfGhiSVO1NEBw\iByLkC1PUDPxE1?	NWraeHNwOTl\|MUe0OVA>
SHSY5Y	NXOxTHFZU2mwYYPlJGF{e2G7	M1\yVVExKM7:TR?=	MmrwOFghcA>?	NGjLd4ZFVVOR	MVPJcohq[mm2aX;uJI9nKEiGQVOge4l1cCCLQ{WwJI9nKDBwNTFOwG0>	NHvabowyQTN2NEG3OS=>
SHSY5Y	NU\1NndXS3m2b4TvfIlkKEG\|c3H5	NWm3epVtOTBizszN	M3HYUlQ5KGh?	NVvxeo81TE2VTx?=	NHLXbXZKSzVyPUKg{txO	NUTmVGMxOTl\|NESxO\|U>
DMS114	M2Hrfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MljZOFghcA>?		M3\ndGdKPTB;Mj65JO69VQ>?	NUT0R4E1OTl2MUmyNFU>
HBC5	MkHnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M1vJUVQ5KGh?		NEL4XFFIUTVyPUG3JO69VQ>?	MkHYNVk1OTl{MEW=
SNB78	NV;kbZVIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M3XqXlQ5KGh?		NFnLRVVIUTVyPUG2JO69VQ>?	NXvtW4E4OTl2MUmyNFU>
HeLa	M17uVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1vWXlczKGh?	Mnz4SG1UVw>?	MnXVTWM2OD1yLkS2JO69VQ>?	NG\HbJIyQTR2MUi0Oi=>
BHK	MYjLbY5ie2ViQYPzZZk>	MYe1JO69VQ>?	M{GxPFI1KGh?	MWLEUXNQ	MlXsTY5pcWKrdHnvckBw\iCKRFHDO{BmgHC{ZYPz[YQh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gdIxie22jIH3lcYJz[W6nIF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4>	M3vOR\|E6QTZ4N{i5
CFBE41o-	NFvw[Y9McW6jc3WgRZN{[Xl?	MYG1JO69VQ>?	NWrpNVFGQCCq	NV\rbZlFTE2VTx?=	NGf4R2NKdmirYnn0bY9vKG:oIFjERWMh[XO\|ZYPz[YQh[XNiaInw[ZJi[2W2eXzheIlwdiCxZjDobZN1d26nIFiz	MlLhNVk6PjZ5OEm=
CFBE41o-	M2jrN2tqdmG\|ZTDBd5NigQ>?	M4iwblUh\|ryP	NFnE[XA1KGh?	M1zjXGROW09?	MX;Jcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6lcnXhd4UhcW5ibYX0ZY51KE[mZXz0ZVUxQCCFRmTSJJBzd3SnaX6gcIV3\Wx?	M1fjRlE6QTZ4N{i5
CFBE41o-	NXi3enN[U2mwYYPlJGF{e2G7	MnjJNUDPxE1?	M3XuVlEhcA>?	MULEUXNQ	MkDHTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIFPGWHIheHKxdHXpckBt\X[nbB?=	MXKxPVk3Pjd6OR?=
Primary bronchial epithelial cell	NX3FdmlGU2mwYYPlJGF{e2G7	MVqxJO69VQ>?	M365S\|I1KGh?	NG\POJZFVVOR	M{e5NGlvcGmkaYTpc44hd2ZiSFTBR\|ch[XO\|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJI12fGGwdDDG[IVtfGF3MEigR2ZVWiCycn;0[YlvKGGyaXPhcEB{fXKoYXPlJIxw[2GuaYrheIlwdg>?	NIH1XnoyQTl4Nke4PS=>
CFBE41o-	M{PyeGtqdmG\|ZTDBd5NigQ>?	NIXmOokyKM7:TR?=	MoO1OUBl[Xm\|	MUfEUXNQ	MkT3TY5pcWKrdHnvckBw\iCKRFHDO{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDzeIFjcWyrenH0bY9vKG:oIF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4>	MXOxPVk3Pjd6OR?=
CFBE41o-	MkHTT4lv[XOnIFHzd4F6	NFu4U2IyKM7:TR?=	Mmi4NlQhcA>?	NW\PZ3RiTE2VTx?=	MX;Jcohq[mm2aX;uJI9nKEiGQVO3JIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4hfHKjZn\pZ4tqdmd?	NXOweWV3OTl7Nk[3PFk>
CFBE41o-	MULLbY5ie2ViQYPzZZk>	M1vUOVUh\|ryP	M4rq[FI1KGh?	M2m3RWROW09?	NVnDNYtGUW6qaXLpeIlwdiCxZjDISGFEPyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBz[XSnIH;mJI1ifHW{YYTpc44hd2ZiQ1\UVkBxem:2ZXnuJJRwKGm2czDncJlkd2[xcn2=	MoTlNVk6PjZ5OEm=
CFBE41o-	NH\LTHJMcW6jc3WgRZN{[Xl?	MmHzOUDPxE1?	MVSyOEBp	NE\WfYFFVVOR	NHHyeZVKdmirYnn0bY9vKG:oIFjERWM4KGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJJN1[WKrbHn0fUBw\iCIZHXseIE2ODhiQ1\UVkBxem:2ZXnu	NWK0fHFSOTl7Nk[3PFk>
CFBE41o-	MW\LbY5ie2ViQYPzZZk>	NXvZRlgxPSEQvF2=	MkO5NlQhcA>?	MmHpSG1UVw>?	MoDXTY5pcWKrdHnvckBw\iCKRFHDO{Bie3Onc4Pl[EBieyClb4Ly[YN1cW:wIH;mJI12fGGwdDDG[IVtfGF3MEigR2ZVWiC2cnHm[olkc2mwZzD0c{Bk\WyuIIP1doZi[2ViYYOg[4x6[2:ob4Lt	NUDLd3d3OTl7Nk[3PFk>
Primary bronchial epithelial cell	MXrLbY5ie2ViQYPzZZk>	NH\jXVk2KM7:TR?=	Ml3wNlQhcA>?	NVHzN5Q1TE2VTx?=	MXjJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6mdXP0bY9vKG:oIH31eIFvfCCIZHXseIE2ODhiQ1\UVkBxem:2ZXnuJIFxcWOjbDDzeZJn[WOnIHzvZ4FtcXqjdHnvci=>	MWWxPVk3Pjd6OR?=
Primary bronchial epithelial cell	NYnMXG5JU2mwYYPlJGF{e2G7	MYWxJO69VQ>?	MWS5OkBp	NIT4TI5FVVOR	MX7Jcohq[mm2aX;uJI9nKEiGQVO3JIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIIPoc5J1KGOrcnP1bZQh[3W{cnXueJM>	M4D3[FE6QTZ4N{i5
BxPC3	NXjZXXBXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MkTFO\|IhcA>?		MnXtTWM2OD1{Lkeg{txO	MmLJNlAyPDN5N{i=
CAL27	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MojwO\|IhcA>?		M4DhbWlEPTB;Mz63NkDPxE1?	MVGyNFE1Ozd5OB?=
Capan1	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2H6TlczKGh?		NEHHb5lKSzVyPUeuN{DPxE1?	MUGyNFE1Ozd5OB?=
HCC827	NVnHR4d[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MoDPO\|IhcA>?		MWrJR\|UxRTFwODFOwG0>	MXWyNFE1Ozd5OB?=
LNCAP	MlmwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVTWfWtMPzJiaB?=		MnS4TWM2OD1yLkW4JO69VQ>?	NX;GdYRWOjBzNEO3O\|g>
NCI-H2122	NIDifYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MojnO\|IhcA>?		MYLJR\|UxRTdwNTFOwG0>	MWiyNFE1Ozd5OB?=
NCI-H358	NG\zTJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M4TmO\|czKGh?		MoXKTWM2OD1{LkWg{txO	NXTwe49zOjBzNEO3O\|g>
SCC15	NUW1U2g3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MV:3NkBp		M4DIdmlEPTB;Mj60PUDPxE1?	MVmyNFE1Ozd5OB?=
SCC25	M3HkVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M33velczKGh?		M{TYc2lEPTB;MT65N{DPxE1?	M{TnNlIxOTR\|N{e4
SKHEP1	M{LxSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MWG3NkBp		M3LoWWlEPTB;Mz60OkDPxE1?	NH;VeFAzODF2M{e3PC=>
BJ	NGHpSHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVuxNFAh\|ryP	Mn;JOFghcA>?	M1S2eGROW09?	M1HGfWdzd3e2aDDpcohq[mm2aX;uJIF1KDBwMEWgeI8hOTByIIXN	NHjNTG4zODF2M{i0NC=>
MUF	M2XURWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFHnWFkyODBizszN	NWnyPY1nPDhiaB?=	MnrOSG1UVw>?	NYLicY9DT3Kxd4ToJIlvcGmkaYTpc44h[XRiMD6wOUB1dyBzMECgeW0>	MX:yNFE1Ozh2MB?=
Caco-2	NEjxOW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVHBNFc5OTByIN88US=>	MnHiOFhp	NI\tSGRFVVOR	MmjrTWM2OD16LkGg{txO	MkDWNlAyPDN6NEC=
Caco-2	Ml7ST4lv[XOnIFHzd4F6	MlroOUDPxE1?	NUm4OWRHPCCq	MofFSG1UVw>?	NUnrdJJoUW6mdXP0bY9vKG:oIFjERWMudWWmaXH0[YQhcGm\|dH;u[UBi[2W2eXzheIlwdiCLQ{WwJI9nKDBwMEO3JO69VQ>?	NECwfpgzODF2M{i0NC=>
Caco-2	MkDmT4lv[XOnIFHzd4F6	NUD0enNYOC5\|MU[gcm0hfG9iM{GuOkDPxE1?	M4e4eFQhcA>?	NXe4[mtGTE2VTx?=	NV[xW\|B7TXhidnn2c{BqdmirYnn0bY9vKG:oIHj1cYFvKEiGQVOxJJdqfGhiSVO1NEBw\iByLkGxPUDPxE1?	NFewbYszODF2M{i0NC=>
Caco-2	NXPPW4lGU2mwYYPlJGF{e2G7	Mn\INE4{OTZibl2geI8hOzFwNjFOwG0>	M4LY[\|QhcA>?	NEW0cINFVVOR	NYjDcldITXhidnn2c{BqdmirYnn0bY9vKG:oIHj1cYFvKEiGQVOzJJdqfGhiSVO1NEBw\iByLkG0O{DPxE1?	NFLWdlczODF2M{i0NC=>
Caco-2	NHjzXWhMcW6jc3WgRZN{[Xl?	MVK2MlMzKG6PIITvJFY{OiEQvF2=	NGPkXFc1KGh?	M4O0cGROW09?	NFK2e\|ZGgCC4aY\vJIlvcGmkaYTpc44hd2ZiaIXtZY4hUESDQ{Wge4l1cCCLQ{WwJI9nKDF{Lk[g{txO	NFTPfoczODF2M{i0NC=>
Caco-2	NGT5U5FMcW6jc3WgRZN{[Xl?	NID2XZI3NjN{IH7NJJRwKDZ\|MjFOwG0>	NVLoWo9jPCCq	MYfEUXNQ	MmrOSZghfmm4bzDpcohq[mm2aX;uJI9nKGi3bXHuJGhFSUN5IIfpeIghUUN3MDDv[kA1OSEQvF2=	M3jiNVIxOTR\|OESw
Caco-2	MlzCT4lv[XOnIFHzd4F6	NV75U4tLOC5\|MU[gcm0hfG9iM{GuOkDPxE1?	MWK0JIg>	M1nDNmROW09?	NF3rZWJGgCC4aY\vJIlvcGmkaYTpc44hd2ZiaIXtZY4hUESDQ{[=	MWWyNFE1Ozh2MB?=
HepG2	Mn24T4lv[XOnIFHzd4F6	NHrmXIg2KM7:TR?=	NVrCWJV1Pmh?	M3rhSmROW09?	MnnSTY5lfWO2aX;uJI9nKEiGQVOtcYVlcWG2ZXSgbIl{fG:wZTDhZ4V1gWyjdHnvci=>	NHnOdI0zODF2M{i0NC=>
HepG2	NFjyW45McW6jc3WgRZN{[Xl?	NIfDfYM2KM7:TR?=	NGL6d2E3cA>?	NGnpU4FFVVOR	M2DwVWlv\HWldHnvckBw\iCKRFHDMY1m\GmjdHXkJIhqe3SxbnWgbJlx\XKjY3X0fYxifGmxbh?=	MW[yNFE1Ozh2MB?=
HepG2	M16xXmtqdmG\|ZTDBd5NigQ>?	NHvaV5Y2KM7:TR?=	NIDB[2k3cA>?	NGLxR2ZFVVOR	NYPIXmJDUW6mdXP0bY9vKG:oIFjERWMudWWmaXH0[YQh[WyyaHGteJVjfWyrbjDhZ4V1gWyjdHnvci=>	NFfHc\|YzODF2M{i0NC=>
HepG2	M13N[WtqdmG\|ZTDBd5NigQ>?	NFTwZmE2KM7:TR?=	Ml7yOog>	NUj5bZpiTE2VTx?=	MW\JcoR2[3Srb36gc4YhUESDQz3t[YRq[XSnZDDIN{9JPCCqaYP0c45mKGGlZYT5cIF1cW:w	MW[yNFE1Ozh2MB?=
COLO205	M4\yVWtqdmG\|ZTDBd5NigQ>?	NHf0Zm8yOCEQvF2=	NXLJZpFnOjRiaB?=	NIfJTnVFVVOR	NEjQb4VKdmirYnn0bY9vKG:oIFjERWMyKGG\|c3Xzd4VlKGG\|IHnu[JVkfGmxbjDv[kBpcXO2b37lJGg{KGGlZYT5cIF1cW:wIIfpeIghUUN3MDDv[kAzNjJizszN	NV\pVncyOjB2NUGzO\|g>
SCC4	NWnVelRWU2mwYYPlJGF{e2G7	M{nLO\|Eh\|ryP	NGDKW2ozPGh?		NXq2NmdGUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJJR2[nWuaX6gZYNmfHmuYYTpc44>	MlHZNlA1PTJ{MkW=
SCC4	NXHGXGR1U2mwYYPlJGF{e2G7	MUSxJO69VQ>?	NGTVd3kzPGh?		MmLtTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIHjpd5RwdmViYXPleJlt[XSrb36=	NEXYUokzODR3MkKyOS=>
SCC4	MmHqSpVv[3Srb36gRZN{[Xl?	MniwNUDPxE1?	NWnQSWlSPSCvaX6=		NHLZXIlC\2:waYP0JIFkfGm4aYT5JIF1KF[GUjDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZiQ2nQNlQh\2WwZTDlfJBz\XO\|aX;u	NUTzd5pROjB2NUKyNlU>
NB4	NVPyblE{TnWwY4Tpc44hSXO\|YYm=	MYe1JO69VQ>?	NUD6RYFIOjRiaB?=	NVjB[HAyTE2VTx?=	NUfiT3RFS2WubDDjfYNt\SCjcoLld5Qh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZYNkfW23bHH0bY9vKGG2IIDy[U1IOSCyaHHz[S=>	MVqyNFQ6OTR2MB?=
NB4	MoHyT4lv[XOnIFHzd4F6	M1vYUVUh\|ryP	M3;URlI1KGh?	MUDEUXNQ	M{fiU2lvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDhZ4V1gWyjdHWgeJVjfWyrbjDs[ZZmdA>?	NH;WcXYzODR7MUS0NC=>
NB4	NF\MdYZHfW6ldHnvckBCe3OjeR?=	MUi1JO69VQ>?	NETJSI0zPCCq	Mn7qSG1UVw>?	NHn1R5BKdmS3Y4Tpc44hd2ZicEKxW2FHOS:FSWCxJIV5eHKnc4Ppc44>	MnnFNlA1QTF2NEC=
NB4	MnT6T4lv[XOnIFHzd4F6	NWrZSnh5PSEQvF2=	NV7qeFI5OjRiaB?=	M{G3bWROW09?	MnHDTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIHjpd5RwdmViSEOgZYNmfHmuYYTpc44>	NHGzUWYzODR7MUS0NC=>
NUGC3	NFX1fHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4\VR2dKPTB;Mj65OEDPxE1?	MYWyNFg2ODl5MR?=
A549	MnfvSpVv[3Srb36gRZN{[Xl?	MmLUOUDPxE1?	MoL4N{Bp	M2[1RWROW09?	MV\JcoR2[3Srb36gc4Yh[XW2b4DoZYd6KGmwIHj1cYFvKEF3NEmgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hVEN\|SVm=	MoC1NlA5PTV{MEi=
HUT78	MoTDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHmxTpk4OiCq	MW\EUXNQ	M4HyWGdKPTB;MD6zJO69VQ>?	MVGyNFg5PDJyOB?=
U937	NXH1bZJGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NH3GfXE4OiCq	MWfEUXNQ	NWDafnJRT0l3ME2wMlM6KM7:TR?=	MU[yNFg5PDJyOB?=
A431	NGHLfIxEgXSxdH;4bYMhSXO\|YYm=		NXn5R\|Z6PzJiaB?=		M17lOWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGE1OzFiY3XscJMhd3[ncnX4dJJme3OrbnegSWdHWiC5aYToJGlEPTBib3[gOE4zKM7:TR?=	NHvTO2QzOTB6ME[yPS=>
A549	NXnObJhPS3m2b4TvfIlkKEG\|c3H5		NF3GNnQ4OiCq		MkS0R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{BwfmW{ZYjwdoV{e2mwZzDISGFEKHerdHigTWM2OCCxZjCxMlgh\|ryP	MmDCNlExQDB4Mkm=
CAL27	M1TQcGN6fG:2b4jpZ{BCe3OjeR?=		M2OxOVczKGh?		MV;DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDDRWwzPyClZXzsd{BwfmW{ZYjwdoV{e2mwZzDFS2ZTKHerdHigTWM2OCCxZjCzMlIh\|ryP	NIq4XXAzOTB6ME[yPS=>
HeLa	NGnLR4hEgXSxdH;4bYMhSXO\|YYm=		M2fiNlczKGh?		MlLSR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTIVN[SClZXzsd{BwfmW{ZYjwdoV{e2mwZzDISGFEKHerdHigTWM2OCCxZjCxMlUh\|ryP	MW[yNVA5ODZ{OR?=
Sf21	NX[w[IhjU2mwYYPlJGF{e2G7		NWHhe4N[OyCq		NEnJeGdKdmirYnn0bY9vKG:oIF\sZYchfGGpZ3XkJIh2dWGwIILlZ49u[mmwYX70JGhFSUN6IHX4dJJme3OnZDD3bZRpKEmFNUCgc4YhOS5{IN88US=>	NYX1TXBuOjFyOEC2Nlk>
SKBR3	M3u2e2N6fG:2b4jpZ{BCe3OjeR?=		M4q0PFczKGh?		MoPOR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gV2tDWjNiY3XscJMhd3[ncnX4dJJme3OrbnegTGVTOiC5aYToJGlEPTBib3[gNk43KM7:TR?=	MUKyNVA5ODZ{OR?=
SKOV3	MkDLR5l1d3SxeHnjJGF{e2G7		NVf2R2Y3PzJiaB?=		NXXQbpFoS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hW0uRVkOgZ4VtdHNib4\ldoV5eHKnc4PpcochUEWUMjD3bZRpKEmFNUCgc4YhOi5{IN88US=>	NHzJUFgzOTB6ME[yPS=>
COR-L23	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmD3NVAh\|ryP	Mnm0O\|IhcA>?	NHnnPXpFVVOR	NVnSSpQ{T0l3ME2xMlEh\|ryP	NXjBO3M5OjFyOEC2OFc>
DU145	Mki1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Mo\ONVAh\|ryP	MonyO\|IhcA>?	NEDvRoZFVVOR	NUDQd3dUT0l3ME2xMlA2KM7:TR?=	MnrqNlExQDB4NEe=
LoVo	MnzVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MlrpNVAh\|ryP	NEnXfXM4OiCq	MX\EUXNQ	Ml3mS2k2OD1zLkeg{txO	NF;td28zOTB6ME[0Oy=>
MCR5-SV2	M{j4cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NIHG[XUyOCEQvF2=	Mm\EO\|IhcA>?	NXjr[IsxTE2VTx?=	NWeyWVQzT0l3ME2yMlEh\|ryP	NVPSdoFUOjFyOEC2OFc>
HCT116	NHrVU4ZMcW6jc3WgRZN{[Xl?	MVWzNEDPxE1?	NEDSS\|I{OCCq	MYLEUXNQ	NV\XZVVJUW6qaXLpeIlwdiCxZjDISGFEPiCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4Yh[WyyaHGteJVjfWyrbjDhZ4V1gWyjdHnvci=>	MV:yNVA5ODZ2Nx?=
HCT116	MVLLbY5ie2ViQYPzZZk>	NGDBPJU{OCEQvF2=	MmrRN\|AhcA>?	NYrxSFZQTE2VTx?=	MoHkTY5pcWKrdHnvckBw\iCKRFHDNUBie3Onc4Pl[EBieyCrbnT1Z5Rqd25ib3[gbIl{fG:wZTDIN2s6KGGlZYT5cIF1cW:w	MViyNVA5ODZ2Nx?=
U937	MUTLbY5ie2ViQYPzZZk>	MkK4OUDPxE1?	M3rsb\|I1KGh?	MX;EUXNQ	MVrJcohq[mm2aX;uJI9nKGirc4TvcoUh[WOndInseJJidnOoZYLhd4Uh[XO\|ZYPz[YQh[XNiaX7jdoVie2Vib3[gZYNmfHmuYYTpc44hd2ZiaHnzeI9v\SCKMzDheEBMQQ>?	NF\FeGIzOTJ7MkS5Ni=>
U937	M3;R[2tqdmG\|ZTDBd5NigQ>?	M{Lye\|Uh\|ryP	NE[yWmUzPCCq	Mmi4SG1UVw>?	NUGyNGNVUW6qaXLpeIlwdiCxZjDobZN1d26nIHHj[ZR6dHS{YX7z[oVz[XOnIHHzd4V{e2WmIHHzJIlv[3KnYYPlJI9nKGGlZYT5cIF1cW:wIH;mJIhqe3SxbnWgTFMh[XRiS{G4	MnTNNlEzQTJ2OUK=
U937	NFjkRnNMcW6jc3WgRZN{[Xl?	M4TjbVUh\|ryP	NV\UZW9pOjRiaB?=	M{DjPGROW09?	M3j3cWlvcGmkaYTpc44hd2ZiaHnzeI9v\SCjY3X0fYx1emGwc3\ldoF{\SCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDv[kBx[W5vYXPleJlt[XSnZDDobZN1d26nIFi0JIxmfmWu	MnPYNlEzQTJ2OUK=
U937	MV;LbY5ie2ViQYPzZZk>	NHr4NmM2KM7:TR?=	NXH6OFhVOTVibXnu	NITm[ppFVVOR	NVnyfJVxUW6qaXLpeIlwdiCxZjDobZN1d26nIHHj[ZR6dHS{YX7z[oVz[XOnIHHzd4V{e2WmIHHzJIlv[3KnYYPlJI9nKGirc4TvcoUhUDNiYXPleJlt[XSrb36gcIV3\Wx?	MV:yNVI6OjR7Mh?=
A2780	NYHBSlhmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NH;EZ\|M6PiCq	MoXqSG1UVw>?	NETLR49KSzVyPUGuOlIh\|ryP	M3\JOFIyPjN2NEOw
COLO205	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MorFPVYhcA>?	NHLYOmZFVVOR	MVrJR\|UxRTJwMUKg{txO	MUmyNVY{PDR\|MB?=
Hep3B	MnXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M2jweFQ5KGh?	Mn;mSG1UVw>?	NYXycJZLT0l3ME2xMlIyKM7:TR?=	NGe4b\|MzOTdzMkG0Oi=>
GM11272	NXzUdpBDTnWwY4Tpc44hSXO\|YYm=	NHH2[YIyODBibl2=	NH76ZWg4OiCq	NFrXeFZFVVOR	MmL3VoVi[3SrdnH0bY9vKG:oIF3lR5AzKG23dHHueEBmgHC{ZYPzbY9vKGG2IEGwJJRwKDFyMDDuUS=>	Mn7HNlE5PDB5MU[=
CFBE41o	M1fRPGtqdmG\|ZTDBd5NigQ>?	MUe1JO69VQ>?		M1XrTGROW09?	NFvyXG1Fd3ewIILl[5Vt[XSrb36gc4YhUESDQ{egZZQhOC5{IITvJFUhfU1?	MmrkNlE6QDR7NUi=
CFBE41o	NFv1[WRHfW6ldHnvckBCe3OjeR?=	MWKxJO69VQ>?	NXrieHNTOjRiaB?=	NX;3VnV3TE2VTx?=	NH7mfWtT\XO2b4LheIlwdiCxZjDDSnRTKGSnbIThSlUxQCCvdYThcpQhfHKjZn\pZ4tqdmdidH:gZ4VtdCC\|dYLmZYNmKGG\|IHfsfYNw\m:{bYO=	MVSyNVk5PDl3OB?=
DU145	MXzLbY5ie2ViQYPzZZk>	NVO1VFZtOi53IN88US=>	NWjPfm1pOjRiaB?=	MofTSG1UVw>?	MkH3TY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KHWycnXneYxifGmxbjDv[kBxOjG5YX[xJJBzd3SnaX6g[ZhxemW\|c3nvci=>	NIm4epozOjJ4MEG2Oi=>
DU145	MlXXT4lv[XOnIFHzd4F6	NUfzfmNLPSEQvF2=	MnLkNlQhcA>?	M3HXOmROW09?	NIrY[olKdmirYnn0bY9vKG:oIFjERWMh[XO\|ZYPz[YQh[XNiaHnzeI9v\SCKNDDhZ4V1gWyjdHnvci=>	M1fZU\|IzOjZyMU[2
DU145	MU\LbY5ie2ViQYPzZZk>	NVj4OmpYPSEQvF2=	MYKyOEBp	NVLpOWc{TE2VTx?=	MUnJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcGm\|dH;u[UBJOyCqeYDldoFk\XS7bHH0bY9v	NEDWcWQzOjJ4MEG2Oi=>
786-0	Ml2wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3XOV\|YvOiEQvF2=	NHPRNHg4OiCq	NVnLXYVpTE2VTx?=	MV\HTVUxRTNwMjFOwG0>	NFz2V5UzOjR\|NU[2PS=>
A498	NGXzS4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnfGOk4zKM7:TR?=	M1nnb\|czKGh?	M4nCNmROW09?	M1H6fWdKPTB;MT62JO69VQ>?	M{nETlIzPDN3Nk[5
A549/ATCC	NHvkXIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVu2MlIh\|ryP	MoXPO\|IhcA>?	NV[1U3BmTE2VTx?=	NHzaOJZIUTVyPUGuOkDPxE1?	NIDRUG8zOjR\|NU[2PS=>
ACHN	MnTzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3H2c\|YvOiEQvF2=	MYS3NkBp	NWDiT25DTE2VTx?=	M3HocmdKPTB;MT6zJO69VQ>?	Mne3NlI1OzV4Nkm=
BT549	NWW5c29QT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MnvmOk4zKM7:TR?=	NETzdoM4OiCq	Ml7QSG1UVw>?	MkCyS2k2OD1zLkOg{txO	NX[yOXFIOjJ2M{W2Olk>
EKVX	NFfVeolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MmruOk4zKM7:TR?=	M4LIWFczKGh?	NVyzW\|hJTE2VTx?=	M{nUTmdKPTB;MT6zJO69VQ>?	NWK1fJRGOjJ2M{W2Olk>
HCT15	NIrVZVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M2rXPVYvOiEQvF2=	NWjJcGJxPzJiaB?=	MWHEUXNQ	M1HtZWdKPTB;Mj61JO69VQ>?	MmmyNlI1OzV4Nkm=
HOP92	M{LicWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXPVcJAxPi5{IN88US=>	M{fIU\|czKGh?	NWraXo0{TE2VTx?=	MofJS2k2OD12IN88US=>	MnTHNlI1OzV4Nkm=
IGROV1	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M4XMdVYvOiEQvF2=	NYfQUHlSPzJiaB?=	Mnq4SG1UVw>?	MVnHTVUxRTFwMzFOwG0>	M2CzN\|IzPDN3Nk[5
LOXIMVI	M4fRZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnTrOk4zKM7:TR?=	MYC3NkBp	NUXoXVNVTE2VTx?=	M2fZUGdKPTB;MTFOwG0>	MV[yNlQ{PTZ4OR?=
M14	Ml3lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MYm2MlIh\|ryP	M{G3WFczKGh?	MoDDSG1UVw>?	M3fWXWdKPTB;MT6zJO69VQ>?	MYCyNlQ{PTZ4OR?=
MALME-3M	MnqxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MnvVOk4zKM7:TR?=	MmXrO\|IhcA>?	M{DZ[WROW09?	MmPnS2k2OD1yLkOyJO69VQ>?	MnzGNlI1OzV4Nkm=
MCF10A	MoDzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Ml7NOk4zKM7:TR?=	NGjqWWU1QCCq	NFLPVVVFVVOR	M4jiUGdKPTB;OT62JO69VQ>?	NYrO[llQOjJ2M{W2Olk>
MDA-MB-435	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYe2MlIh\|ryP	MXS3NkBp	M330eWROW09?	MnPwS2k2OD1yLkWg{txO	Mnn4NlI1OzV4Nkm=
MDA-MB-468	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M{PtU\|YvOiEQvF2=	M4rQelczKGh?	MoTWSG1UVw>?	NV;VbnJTT0l3ME2wMlY{KM7:TR?=	MYiyNlQ{PTZ4OR?=
MOLT4	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NWKxS29mPi5{IN88US=>	NGeyRpo4OiCq	MXPEUXNQ	Mof5S2k2OD1yLkSg{txO	MkjUNlI1OzV4Nkm=
NCI-ADR-RES	NGHzV2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NET1PW03NjJizszN	MlziO\|IhcA>?	MkL5SG1UVw>?	NELlW4ZIUTVyPUCuNVYh\|ryP	NGjkeXAzOjR\|NU[2PS=>
NCI-H23	NICyeoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVrVPVRPPi5{IN88US=>	NILrVZA4OiCq	NGTFToNFVVOR	NEDw[VZIUTVyPUGg{txO	MnfmNlI1OzV4Nkm=
NCI-H322M	NVHhNYc{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MX[2MlIh\|ryP	MVq3NkBp	M1LWOmROW09?	MW\HTVUxRTBwN{mg{txO	M4r2OVIzPDN3Nk[5
NCI-H460	M1\UWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NYroe4R4Pi5{IN88US=>	NUXhS4t5PzJiaB?=	M1W0WmROW09?	M2[3R2dKPTB;MD63PUDPxE1?	MVuyNlQ{PTZ4OR?=
NCI-H522	NHvaUm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M{PzflYvOiEQvF2=	NFfDcVQ4OiCq	MYXEUXNQ	MoWxS2k2OD1yLkWg{txO	M2XhT\|IzPDN3Nk[5
OVCAR3	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3vuVVYvOiEQvF2=	Mn3lO\|IhcA>?	MYTEUXNQ	NH:5VpFIUTVyPUGuN{DPxE1?	NGHGWmczOjR\|NU[2PS=>
OVCAR4	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NELQVnU3NjJizszN	NXPMcXJ2PzJiaB?=	MUPEUXNQ	MkDZS2k2OD12IN88US=>	NF3VXlYzOjR\|NU[2PS=>
OVCAR5	MlP4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFj0SI83NjJizszN	M{HWZVczKGh?	NXvNSoNLTE2VTx?=	M1ztd2dKPTB;MD63PUDPxE1?	NXTRVoR[OjJ2M{W2Olk>
OVCAR8	NHr3emxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MkP0Ok4zKM7:TR?=	MY[3NkBp	MljWSG1UVw>?	NULZR3hCT0l3ME2wMlUh\|ryP	M1;zW\|IzPDN3Nk[5
RXF393	NI\LNZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mn;aOk4zKM7:TR?=	M3;vbVczKGh?	MYjEUXNQ	NXzabGVkT0l3ME2xMlMh\|ryP	NU[5SYI1OjJ2M{W2Olk>
SF268	M1HRR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXTwSYt1Pi5{IN88US=>	NHTpfpo4OiCq	M{\WNWROW09?	NIr0cm5IUTVyPUGuOkDPxE1?	MUeyNlQ{PTZ4OR?=
SF295	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFLIZ3k3NjJizszN	M2XvW\|czKGh?	NETld2JFVVOR	M1PDdGdKPTB;MT62JO69VQ>?	M1PaU\|IzPDN3Nk[5
SF539	M{C4Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NYTPe3BTPi5{IN88US=>	NGfpbIg4OiCq	MoDBSG1UVw>?	MnmyS2k2OD1{IN88US=>	MVKyNlQ{PTZ4OR?=
SK-MEL-2	NY\KeJduT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MkTZOk4zKM7:TR?=	M1W3SVczKGh?	MlzCSG1UVw>?	MV3HTVUxRTFwMzFOwG0>	NFvrVI4zOjR\|NU[2PS=>
SK-MEL-28	NFj3OXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MV:2MlIh\|ryP	NV\rZ5I3PzJiaB?=	NGq2dlhFVVOR	MWfHTVUxRTFizszN	MV6yNlQ{PTZ4OR?=
SK-MEL-5	M4rJUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M4PoblYvOiEQvF2=	MnXlO\|IhcA>?	MX7EUXNQ	NYDHdWh4T0l3ME2wMlY{KM7:TR?=	NF7nd3ozOjR\|NU[2PS=>
SKOV3	MknJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHLLTIk3NjJizszN	NGflXZk4OiCq	NWnRZoJ3TE2VTx?=	M{DHfmdKPTB;MTFOwG0>	NYKzWIFHOjJ2M{W2Olk>
SN12C	MknvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoHkOk4zKM7:TR?=	NF3FeWM4OiCq	MkS2SG1UVw>?	NHHJPVVIUTVyPUKg{txO	NUfzdVYxOjJ2M{W2Olk>
SNB19	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NWT4TYo5Pi5{IN88US=>	M2POblczKGh?	NWnaZpRUTE2VTx?=	MnzRS2k2OD1yLk[zJO69VQ>?	MkD5NlI1OzV4Nkm=
SNB75	NUTvOFVLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Ml3DOk4zKM7:TR?=	MWO3NkBp	MmjMSG1UVw>?	M3fsbGdKPTB;MD63PUDPxE1?	MWeyNlQ{PTZ4OR?=
SR	Ml;tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NILKW5A3NjJizszN	M4DNelczKGh?	M1q0c2ROW09?	MYfHTVUxRTBwNDFOwG0>	NVK5ZldwOjJ2M{W2Olk>
T47D	NYP3eoxCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MofVOk4zKM7:TR?=	MXu3NkBp	MVzEUXNQ	NYDWcphQT0l3ME2wMlUh\|ryP	NX3UbZdjOjJ2M{W2Olk>
TK10	NVTLSnFUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NFT4VIg3NjJizszN	MkmzO\|IhcA>?	MnLiSG1UVw>?	NHzZN2xIUTVyPUCuOlMh\|ryP	MUmyNlQ{PTZ4OR?=
UACC257	NWW4U4RUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mm\mOk4zKM7:TR?=	MWS3NkBp	Mn\MSG1UVw>?	M4S4TGdKPTB;MD61JO69VQ>?	M3e0XlIzPDN3Nk[5
UACC62	NYeybZV{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NXfKSINsPi5{IN88US=>	NH;sOnM4OiCq	NH3pRVFFVVOR	M4XBcGdKPTB;MD60JO69VQ>?	NX3Fbm93OjJ2M{W2Olk>
UO31	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3LLclYvOiEQvF2=	M3;YT\|czKGh?	NHPh[lRFVVOR	M4Sze2dKPTB;MD61JO69VQ>?	MWGyNlQ{PTZ4OR?=
Hep3B	MlH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWq0PEBp	NXH4XG5ZTE2VTx?=	NFvjV5dIUTVyPUCuOlkh\|ryP	NX2xVHhHOjJ2M{m4OlM>
BE(2)-C	M3:z[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NGf0cow4OiCq	NWThTGxpTE2VTx?=	NWnpN5dIUUN5ME2yJO69VQ>?	NVfsSmoxOjJ7M{KzNVY>
Bel7402	NULiWHhJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MWS3NkBp	NFL1TlFFVVOR	M1u0PWdKQTB;MUeg{txO	MomwNlMxPjF\|N{[=
Bel7404	M3PUZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M{e5T\|czKGh?	NHj4U4dFVVOR	MV7HTVkxRTF6IN88US=>	NILtNIozOzB4MUO3Oi=>
BGC823	NF7JWGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MVS3NkBp	MWDEUXNQ	MUTHTVkxRTdwNTFOwG0>	MWWyN\|A3OTN5Nh?=
MGC803	M4nnNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3TodlczKGh?	MV7EUXNQ	NV;lT3c{T0l7ME2xNE45KM7:TR?=	MnrHNlMxPjF\|N{[=
SGC7901	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVe3NkBp	NWXpdopETE2VTx?=	MWXHTVkxRTlwNDFOwG0>	MYeyN\|A3OTN5Nh?=
SKHEP1	Mn\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHPhdZg4OiCq	Mn3PSG1UVw>?	NXHCZ3pTT0l7ME2xO{DPxE1?	NXPqSo9mOjNyNkGzO\|Y>
SMMC7721	NVizTndyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYfSeo9EPzJiaB?=	M{f4NGROW09?	Ml\HS2k6OD1{MDFOwG0>	NIPyd\|kzOzB4MUO3Oi=>
NUGC3	NUD6NYhXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYexNEDPxE1?			M2PnWWdKRTJwOUSg{txO	NXLZdGhIOjNzNkOzN\|I>
A2780 CisR	NYrFXFdtU2mwYYPlJGF{e2G7		M3rWfVE5KGh?		MoL2TY5pcWKrdHnvckBw\iCKRFHDJJdqfGhiSVO1NEBw\iByLkS0JO69VQ>?	NUXuTlFuOjN{NUK2NFM>
CAL27 sens	NYixTWNGU2mwYYPlJGF{e2G7		NF;pPZMyQCCq		NIjLUVlKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR\|UxKG:oIECuN\|Yh\|ryP	MnTMNlMzPTJ4MEO=
CAL27 CisR	NWjvZYRYU2mwYYPlJGF{e2G7		NXPXToJKOThiaB?=		M3fMWmlvcGmkaYTpc44hd2ZiSFTBR{B4cXSqIFnDOVAhd2ZiMD62NUDPxE1?	NImxXm4zOzJ3Mk[wNy=>
KYSE-510 CisR	M{K5Z2tqdmG\|ZTDBd5NigQ>?		MVOxPEBp		NGPENJVKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR\|UxKG:oIECuOVkh\|ryP	MY[yN\|I2OjZyMx?=
KYSE-510 sens	NIe3eGpMcW6jc3WgRZN{[Xl?		MlvhNVghcA>?		NWHOd4VLUW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlch\|ryP	NF\QcmMzOzJ3Mk[wNy=>
MDA-MB-231 sens	MnvHT4lv[XOnIFHzd4F6		M4K2e\|E5KGh?		NF2zTVRKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR\|UxKG:oIECuOlEh\|ryP	MlSzNlMzPTJ4MEO=
MDA-MB-231 CisR	MXzLbY5ie2ViQYPzZZk>		NESxNm4yQCCq		MmnCTY5pcWKrdHnvckBw\iCKRFHDJJdqfGhiSVO1NEBw\iByLk[xJO69VQ>?	M13XUlI{OjV{NkCz
ES2	MkH4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NHzEfHU1QCCq	M{XWNGROW09?	M2\J[GlEPTB;MUKuO{DPxE1?	MWOyN\|Q6OzR2OR?=
MDA-MB-231	M3TB[2tqdmG\|ZTDBd5NigQ>?	MUCxNEDPxE1?	MmS0N\|AhdWmw	Ml6wSG1UVw>?	NXnG[lJUUW6qaXLpeIlwdiCxZjDISGFEOmF?	MV[yN\|Q6OzR2OR?=
MDA-MB-231	MlruT4lv[XOnIFHzd4F6	MXyxJO69VQ>?	M1X1UFI1KGh?	M{nUXGROW09?	M3vrSGlvcGmkaYTpc44hd2ZiSFTBR\|Yh[XO\|ZYPz[YQh[XNiYXPleJlt[XSrb36gcIV3\Wy\|IH;mJJR2[nWuaX6=	NYnHc4NROjN2OUO0OFk>
HS68	NHnkPFlEgXSxdH;4bYMhSXO\|YYm=	MVqxNEDPxE1?	MX23NkBp	MX;EUXNQ	NV;pV3hyUUN3ME20MlYh\|ryP	NXfqfmVlOjN3N{C1OFI>
MEF	NVTrRWtSS3m2b4TvfIlkKEG\|c3H5	M4rI[lExKM7:TR?=	MUO3NkBp	M4jHPGROW09?	M4TKdmlEPTB;ND60JO69VQ>?	MV6yN\|U4ODV2Mh?=
BGC823	NVTZc41DT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			Ml7rSG1UVw>?	MmDSS2k2OD1\|LkC5JO69VQ>?	NGm4NGwzOzZyMUewOi=>
High5	MofFT4lv[XOnIFHzd4F6		NHLqeWIzPCCq		MVPJcohq[mm2aX;uJI9nKGi3bXHuJJJm[2:vYnnuZY51KEiGQVO2JJdqfGhiSVO1NEBw\iByLkC5JO69VQ>?	NFGycYEzOzZyMkWyNy=>
High5	M3zrUmtqdmG\|ZTDBd5NigQ>?		MYKyOEBp		NUSwbI5pUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEOSC5aYToJGlEPTBib3[gNE4yOiEQvF2=	MYGyN\|YxOjV{Mx?=
High5	MU\LbY5ie2ViQYPzZZk>		MkH4NlQhcA>?		NYrMfWFjUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEOyC5aYToJGlEPTBib3[gNE4yPyEQvF2=	NY\PcXBUOjN4MEK1NlM>
A549	NGLFcXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M{\4VWROW09?	M1;kc2lEPTB;MT6wO\|kh\|ryP	NFLydJozOzZ2NEKxNC=>
HCT116	NVvuSYJxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MorHSG1UVw>?	M3HZdGlEPTB;MD63OVch\|ryP	NXXFN2lMOjN4NESyNVA>
K562	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?			M1T2XWROW09?	MneyTWM2OD1yLk[0OUDPxE1?	M4W3XlI{PjR2MkGw
GBC-SD	NXnhcXN6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M33EbVUh\|ryP	MljrO\|IhcA>?	NXL6OY1rTE2VTx?=	M2n5VGlEPTB;MUSuPEDPxE1?	M{XDXFI{PzB5Mk[w
HGC27	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NGPMfIc2KM7:TR?=	MUK3NkBp	MXvEUXNQ	NYnt[W9oUUN3ME21MlQh\|ryP	NEnvUVczOzdyN{K2NC=>
HL60	MoTiT4lv[XOnIFHzd4F6	NYLISVdUPSEQvF2=	M3rUO\|I1KGh?	Mm\sSG1UVw>?	MmSzTY5pcWKrdHnvckBw\iCKRFHD	NFvkSXMzOzdyN{K2NC=>
Vero	NYj5dndtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MUe3NkBp	NXvT[phCTE2VTx?=	MV;JR\|UxRTBwOTFOwG0>	NGHvUG8zOzd6NkS1Ni=>
NCI60	NVfUNoJyS3m2b4TvfIlkKEG\|c3H5		NVj4bnk3PDhiaB?=	NX\lfmJETE2VTx?=	MVHHTV0xNjV\|IN88US=>	MXeyOFAyPTN{Nx?=
SW620	M2f0cmN6fG:2b4jpZ{BCe3OjeR?=		M1XER\|Q5KGh?	MnLlSG1UVw>?	M3jJfWdKRTBwNUSg{txO	NX[5W3ZWOjRyMUWzNlc>
U251	NUK2UmI5S3m2b4TvfIlkKEG\|c3H5		MU[0PEBp	NEHifIZFVVOR	NWj1[XA6T0l;MT61N{DPxE1?	MkDnNlQxOTV\|Mke=
KM12	MUXDfZRwfG:6aXOgRZN{[Xl?		MXO0PEBp	M3zHOGROW09?	M{H5S2dKRTFwOEig{txO	Moq2NlQxOTV\|Mke=
Hs578T	NVn0VYJzS3m2b4TvfIlkKEG\|c3H5		MkHaOFghcA>?	MWrEUXNQ	M3z6fWdKRTRwOEOg{txO	M4n0RVI1ODF3M{K3
MDA-MB-231	NVvueWRsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MV:0PEBp		NYLKWHBDUUN3ME2wMlE3KM7:TR?=	MXOyOFA6PTBzNh?=
MCF7	NFH1XHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NYPZUJB7PDhiaB?=		NIK5VXNIUT1yLkS1JO69VQ>?	NGnYfnAzPDFzOUW1OS=>
MDA-MB-435	M4HtS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MmnYOFghcA>?		MoXnS2k:OC56ODFOwG0>	NGH5c2EzPDFzOUW1OS=>
AsPC1	Mn3nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoT4N\|Ah\|ryP	MYm0PEBp	NHn2bYVFVVOR	NH63fHJKSzVyPUOuOlYh\|ryP	MkTqNlQyQDV\|N{i=
Jurkat E6.1	MmjCT4lv[XOnIFHzd4F6		NXq5XWlJOiCq	MmTOSG1UVw>?	NVHacoZLUW6qaXLpeIlwdiCxZjDISGFEPCC5aYToJGlEPTBib3[gNE4xPCEQvF2=	MlzXNlQzPjF6NkK=
KG1	M4L2Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NU\vXmVxPDhiaB?=		MV7JR\|UxRTFwMUWg{txO	NXzFW4FlOjR3MkWwNFM>
HEL	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M2DDVVQ5KGh?	NVPCT2ZsTE2VTx?=	NFz5[XBKSzVyPUCuOFkh\|ryP	NVLjWY86OjR4OUSwOVU>
HSC3	M3SxVmN6fG:2b4jpZ{BCe3OjeR?=		NYrQd\|hGOTJiaB?=	MUDEUXNQ	M2D4NGlEPTB;MD63NUDPxE1?	NXryXZVrOjR5Nk[1OlA>
HT-29	NVzmTotnS3m2b4TvfIlkKEG\|c3H5		NY\E[FVDOTJiaB?=	M{fi[GROW09?	NUn3O5kzUUN3ME2wMlczKM7:TR?=	NXTPe\|MzOjR5Nk[1OlA>
KB	MkfyR5l1d3SxeHnjJGF{e2G7		NULBeYNkOTJiaB?=	MXrEUXNQ	MknHTWM2OD1yLke1JO69VQ>?	NYjEcIhqOjR5Nk[1OlA>
H460	NXHpNnZLS3m2b4TvfIlkKEG\|c3H5		MXOxNkBp	M3[zbWROW09?	NV75flBXUUN3ME2wMlgzKM7:TR?=	MXqyOFc3PjV4MB?=
MONE1	MWnDfZRwfG:6aXOgRZN{[Xl?		MUmxNkBp	MVfEUXNQ	MnPKTWM2OD1zLkG4JO69VQ>?	NF;5Z\|IzPDd4NkW2NC=>
MKN45	NFywToxEgXSxdH;4bYMhSXO\|YYm=		M1HpUFEzKGh?	NWm5cHp2TE2VTx?=	MWHJR\|UxRTFwMkWg{txO	NG\1VGIzPDd4NkW2NC=>
TSGH	MXnDfZRwfG:6aXOgRZN{[Xl?		Mm\sNVIhcA>?	NWnlfpR7TE2VTx?=	NUnxcFJwUUN3ME2yMlA6KM7:TR?=	NV6zWI1iOjR5Nk[1OlA>
HL60	MkfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NYfmO4tHPzJiaB?=	MUTEUXNQ	NUfJ[mY4T0l3ME2wMlk{KM7:TR?=	M2rrXlI1QTByNUCw
HEK293	NX22fHJmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MknpO\|IhcA>?	NVju[Jh2TE2VTx?=	M4TFVGdKPTB;MUOg{txO	M33CV\|I1QTByNUCw
Jurkat	M2rGVGN6fG:2b4jpZ{BCe3OjeR?=	M13IOFExOCEQvF2=	MmXIO\|IhcA>?		NX32NGw3T0l3ME2wMlkh\|ryP	NF3ie4QzPDlyMEe0Ny=>
GM15850	Mn\ZT4lv[XOnIFHzd4F6	MW[yMlUh\|ryP	NELM[pY6PiCq	M{P5c2ROW09?	Mke4[I9meyCwb4SgbY5pcWKrdDDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFMhdHm\|aX7lJFE1KGGlZYT5cIF1cW:wIH;mJGZZViCpZX7l	NV;zWW1MOTZ7MkGzOlc>
GM15850	M2DGR2tqdmG\|ZTDBd5NigQ>?	M1rCdVIvPSEQvF2=	MYK5OkBp	NWPSNXhzTE2VTx?=	NFfidGVld2W\|IH7veEBqdmirYnn0JGhFSUNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hcGm\|dH;u[UBJPCCueYPpcoUhPSCjY3X0fYxifGmxbjDv[kBHYE5iZ3Xu[S=>	M1HYWVE3QTJzM{[3
GM15850	MoHIT4lv[XOnIFHzd4F6	MorzNk42KM7:TR?=	M{Da[Fk3KGh?	NHnSfFlFVVOR	M1frb4Rw\XNibn;0JIlvcGmkaYSgTGRCSyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBpcXO2b37lJGg1KGy7c3nu[UAyOiCjY3X0fYxifGmxbjDv[kBHYE5iZ3Xu[S=>	NIXkcnEyPjl{MUO2Oy=>
GM15850	Moi2T4lv[XOnIFHzd4F6	NVzwd2NEOi53IN88US=>	M1HCb\|k3KGh?	NGrCeIJFVVOR	M{TtdYRw\XNibn;0JIlvcGmkaYSgTGRCSyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBpcXO2b37lJGg{KGy7c3nu[UA6KGGlZYT5cIF1cW:wIH;mJGZZViCpZX7l	NUXLV\|F6OTZ7MkGzOlc>
GM15850	M1OzZWtqdmG\|ZTDBd5NigQ>?	NVqwO25ROi53IN88US=>	M2j4VFk3KGh?	Mn[0SG1UVw>?	M4PnS4Rw\XNibn;0JIlvcGmkaYSgTGRCSyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBpcXO2b37lJGg1KGy7c3nu[UA5KGGlZYT5cIF1cW:wIH;mJGZZViCpZX7l	M1S5RlE3QTJzM{[3
GM15850	NHi3TWFMcW6jc3WgRZN{[Xl?	NXe5[WZEOi53IN88US=>	NXn4UHRIQTZiaB?=	NYrsXZJETE2VTx?=	M161fYRw\XNibn;0JIlvcGmkaYSgTGRCSyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBpcXO2b37lJGg1KGy7c3nu[UAyPiCjY3X0fYxifGmxbjDv[kBHYE5iZ3Xu[S=>	M4rpflE3QTJzM{[3
GM15850	NUK1XG9pTnWwY4Tpc44hSXO\|YYm=	MX[1JO69VQ>?	NIntNYYyOiCq	MkfhSG1UVw>?	MY\oZZMhdm9iZX\m[YN1KG:wIF\YUkBuWk6DIHX4dJJme3Orb36=	Ml;TNVY6OjF\|Nke=
U937	MYTLbY5ie2ViQYPzZZk>	MUm1JO69VQ>?	NXLSWFJyOjRiaB?=	NVe4V5l[TE2VTx?=	M{LyT4hieyCwbzDl[oZm[3Rib36gZYxxcGFidIXieYxqdiCjY3X0fYxifGmxbh?=	NHTHd2oyPzR2N{e1NC=>
U937	M1mwOGtqdmG\|ZTDBd5NigQ>?	M4HyT\|Eh\|ryP	NHLLfY0zPCCq	M2fEOGROW09?	MoTtbIF{KG6xIHXm[oVkfCCxbjDhcJBp[SC2dXL1cIlvKGGlZYT5cIF1cW:w	M1vCVFE4PDR5N{Ww
PANC1	MU\GeY5kfGmxbjDBd5NigQ>?	M2\UUFEh\|ryP	Ml\2NlQhcA>?		MX3kc4V{KG6xdDDpcoNz\WG\|ZTDpckBxOjetaYCxJIdmdmViZYjwdoV{e2mxbh?=	NXTw[JBHOTd3OEi3OFQ>
PANC1	M{nqOmZ2dmO2aX;uJGF{e2G7	NHX5cZAyKM7:TR?=	NYr3PYNPPDhiIHi=		M{jSb4Rw\XNibn;0JIlv[3KnYYPlJIlvKHB{N3vpdFEh\2WwZTDlfJBz\XO\|aX;u	M2XIUFE4PTh6N{S0
Caco-2	M362R2Z2dmO2aX;uJGF{e2G7	Mlf2OUDPxE1?	NVK4Wo93OjRiaB?=	Mn[5SG1UVw>?	M1zVW4Rw\XNibn;0JIlv\HWlZTDQNlFYSUZzIHflcoUh\XiycnXzd4lwdg>?	M1K3b\|IxOTR\|OESw
SCC4	MXrGeY5kfGmxbjDBd5NigQ>?	NFTSWWEyKM7:TR?=	M3ftRVExKG2rbh?=	MX3EUXNQ	NVnTN5ZkcGG\|IH7vJIFod26rc4SgZYN1cX[rdImgZZQhXkSUIHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iCFWWCyOEBo\W6nIHX4dJJme3Orb36=	MUOyNFQ2OjJ{NR?=
A549	MYHGeY5kfGmxbjDBd5NigQ>?	NHzuelE2KM7:TR?=	NYLVTFQ1OyCq	MWHEUXNQ	MX;kc4V{KG6xdDDpcoR2[2ViYYX0c5Bp[We7IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKEyFM1nJ	NUjmTmJZOjB6NUWyNFg>
HCT116	MnnmT4lv[XOnIFHzd4F6	MnHsNE4{KM7:TR?=	Ml\VN\|AhcA>?	NH62fZdFVVOR	M{DEcYRw\XNibn;0JIlvcGmkaYSgTGRCSzFiYYPz[ZN{\WRiYYOgbY5lfWO2aX;uJI9nKGirc4TvcoUhUDONOTDhZ4V1gWyjdHnvci=>	M1;z[lIyODhyNkS3
HepG2	NGS1THVHfW6ldHnvckBCe3OjeR?=	MkHKNVAh\|ryP	M3PU[VI1KGh?	NVXZOW1bTE2VTx?=	M1XHfIRw\XNibn;0JIlv\HWlZTDhdI9xfG:\|aYOgZZN{\XO\|ZXSgZZMhcHmyZYLhZ4V1gWyjdHnvckBw\iCyNUO=	NWraVmtNOjF3NEi1PFI>
GM11272	MnfsSpVv[3Srb36gRZN{[Xl?	M2DuTFAvOSEQvF2=	NVLzOpRjPzJiaB?=	NV3DUGpSTE2VTx?=	MoLm[I9meyCwb4SgdoVi[3SrdnH0[UBO\UOyMjDteZRidnRiZYjwdoV{e2mxbh?=	Mmq2NlE5PDB5MU[=
MDA-MB-231	M4Owb2tqdmG\|ZTDBd5NigQ>?	M3PTcFExKM7:TR?=	MoXFOUBucW5?	NV;DUXR7TE2VTx?=	M3PhU4Rw\XNibn;0JIlvcGmkaYSgTGRCSzKj	MW[yN\|Q6OzR2OR?=
MDA-MB-231	NYfwXYc4U2mwYYPlJGF{e2G7	MmexNUDPxE1?	Ml;ONlQhcA>?	NGfyUGtFVVOR	MYXkc4V{KG6xdDDpcohq[mm2IFjERWM3KGG\|c3Xzd4VlKGG\|IHHj[ZR6dGG2aX;uJIxmfmWuczDv[kB1fWK3bHnu	MojnNlM1QTN2NEm=
K562	Mnm2T4lv[XOnIFHzd4F6				NFrRWINld2W\|IH7veEBqdmirYnn0JGhFSUN?	M4i0bFI{PTlzMUGx
Jurkat	MXvDfZRwfG:6aXOgRZN{[Xl?	M4DHSFIxKM7:TR?=	NYPmcXAxPzJiaB?=	M1PERmROW09?	NWXMemdkdm9iY4n0c5RwgGmlaYT5JIF{e2W\|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9v	M{HhUlI1OzB2M{S4
HCT116	MYPBdI9xfG:\|aYOgRZN{[Xl?	NYrGSJlrOyEQvF2=	NETaeZMzPCCq	MlXvSG1UVw>?	NEL1OpJld2W\|IH7veEBqdmS3Y3WgZZBweHSxc3nzJIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIIC1N{Bxem:2ZXnuJIxmfmWu	Mn\WNlQ4PjZ3NkC=
KASUMI-1	M1rJWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mmf5TWM2OD17OT6xO{BvVQ>?	MVzTRW5ITVJ?
KARPAS-45	NVqxNZdFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkW0TWM2OD1zN{OuPFkhdk1?	MoDlV2FPT0WU
BHT-101	NHzHVodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYH5PIxFUUN3ME2yOFQvOThibl2=	NG\4UY1USU6JRWK=
H9	M2n4Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFnvW\|ZKSzVyPUK1OU4xPCCwTR?=	MV;TRW5ITVJ?
PA-1	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV3JR\|UxRTJ6Nj6yOkBvVQ>?	M2rYOHNCVkeHUh?=
NEC8	NVHNWnRTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2DZ[GlEPTB;Mki5MlM5KG6P	NWjLeWxOW0GQR1XS
MHH-PREB-1	MkjxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVKzTIdXUUN3ME2yPVQvPTNibl2=	NFiyZo1USU6JRWK=
NB7	Mn7iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mk\STWM2OD1\|NEWuO\|Qhdk1?	NUPFS4xrW0GQR1XS
A3-KAW	MofkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVLJR\|UxRTRyMD61PUBvVQ>?	NXeyVFNKW0GQR1XS
NB69	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWTLO4dwUUN3ME20NVEvPzFibl2=	NYnUeHhkW0GQR1XS
EoL-1-cell	NE\JfWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1;MS2lEPTB;NEW0NlUhdk1?	NVnoOmJ7W0GQR1XS
CHP-212	NVXXcXo1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUm4PJVyUUN3ME20OVcvPTNibl2=	M3rlT3NCVkeHUh?=
C2BBe1	MmTMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1LtdGlEPTB;NEeyMlE6KG6P	MmrkV2FPT0WU
697	NHHJUVVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWnJR\|UxRTR5Mz60NUBvVQ>?	M4TyVXNCVkeHUh?=
BCPAP	NILRZWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUTJR\|UxRTVyMT60NkBvVQ>?	NYnOVI9JW0GQR1XS
L-363	NXH6cYRlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIe3cGZKSzVyPUWwN{4yKG6P	Ml[yV2FPT0WU
ES8	NXXHO4piT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGjJVWZKSzVyPUWyN{42OyCwTR?=	NHzvU2ZUSU6JRWK=
BE-13	NVi0PWVnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3rIOGlEPTB;NUK2Mlk3KG6P	M3jEbXNCVkeHUh?=
CTB-1	NGjifZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIG4OVVKSzVyPUWzO{46OiCwTR?=	MmT4V2FPT0WU
HD-MY-Z	NVW5fWpwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmnITWM2OD13M{iuNVMhdk1?	NVK3dmVXW0GQR1XS
NKM-1	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NH3FeGpKSzVyPUW0OE4zPyCwTR?=	M1vDZnNCVkeHUh?=
NCI-H720	M{Ptemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mkf1TWM2OD13NkCuNVghdk1?	NXHQXYJFW0GQR1XS
KY821	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmDpTWM2OD13NkOuNlUhdk1?	NIe5VZVUSU6JRWK=
OVCAR-5	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYW5XXZYUUN3ME21O\|YvOTFibl2=	MWjTRW5ITVJ?
CTV-1	NHLv[XpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NV3sWFBOUUN3ME21PFEvPTZibl2=	MlXjV2FPT0WU
P12-ICHIKAWA	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NX;zTopLUUN3ME21PVYvPTFibl2=	NWXFN5AxW0GQR1XS
DB	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmK4TWM2OD13OUiuOVchdk1?	M4X4UXNCVkeHUh?=
CHL-1	M{Hiemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVrJR\|UxRTZ2Mj6wPEBvVQ>?	M{nISHNCVkeHUh?=
A4-Fuk	NWfzcJRyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkDQTWM2OD14NESuPVEhdk1?	NUPnT\|dKW0GQR1XS
MV-4-11	M{HmSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml3mTWM2OD14NUmuNUBvVQ>?	MoXHV2FPT0WU
RPMI-8226	NVrTRmlDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHr6N29KSzVyPU[3PE4yQCCwTR?=	NVm5N3FZW0GQR1XS
NB14	Mn34S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1j3Z2lEPTB;Nkm2Mlk2KG6P	NUjTS2EzW0GQR1XS
DOHH-2	NUnm[FRoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlXWTWM2OD15ME[uOlghdk1?	MYrTRW5ITVJ?
D-423MG	M2i3Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWrJR\|UxRTdyNj64PUBvVQ>?	MVvTRW5ITVJ?
D-283MED	NFq5bVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlP5TWM2OD15MUSuNVQhdk1?	NFPnR\|NUSU6JRWK=
ES1	NHH5fGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFXkeG9KSzVyPUeyOE41KG6P	MYrTRW5ITVJ?
GOTO	NG\yd\|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmW5TWM2OD15MkmuNVIhdk1?	MoSzV2FPT0WU
NCI-H209	NWPVcHI1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{PJTmlEPTB;N{K5Mlkhdk1?	NHLoTYRUSU6JRWK=
MOLT-13	M2\qRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXuxVmQ3UUN3ME23N\|gvQThibl2=	M4K4OXNCVkeHUh?=
ATN-1	NHTCdHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NY\MWZlwUUN3ME23OFAvOjhibl2=	Mm\YV2FPT0WU
DU-4475	NUDU[lVzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mo\ETWM2OD15NUGuPVEhdk1?	NGnhVItUSU6JRWK=
NB10	NV;YZZpmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MX\JR\|UxRTd3MT65NkBvVQ>?	NVPTfWl4W0GQR1XS
KG-1	MoDES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlPQTWM2OD15N{WuOFUhdk1?	MmToV2FPT0WU
MOLT-4	M2DrNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVTqcI5yUUN3ME23PFcvPDZibl2=	M1PienNCVkeHUh?=
TE-1	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGXSO3hKSzVyPUe5NU4yKG6P	M3uxeXNCVkeHUh?=
SBC-1	NWjQTZBLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGTnNIJKSzVyPUe5N{45PCCwTR?=	M1XXRXNCVkeHUh?=
HEL	NUG3WXFzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MX\JR\|UxRThyNj6wPEBvVQ>?	M{L5WXNCVkeHUh?=
SK-MEL-2	M2ruPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGr1NWVKSzVyPUiwPU41PCCwTR?=	MUDTRW5ITVJ?
KU812	MnHzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFfH[ZRKSzVyPUixN{4yKG6P	MWrTRW5ITVJ?
RPMI-8866	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3XlO2lEPTB;OEGzMlY4KG6P	MkXMV2FPT0WU
ALL-PO	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NUXEOVRuUUN3ME24NVQvPjZibl2=	NVHoXGQzW0GQR1XS
LU-139	NXHqUFlxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYHsbpoxUUN3ME24NlIvQDZibl2=	MkeyV2FPT0WU
RS4-11	M1zrRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVnEZpI3UUN3ME24N\|IvPDVibl2=	NYjkUFZ7W0GQR1XS
EW-18	MlHGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHK4OG9KSzVyPUizNk46PiCwTR?=	Mor0V2FPT0WU
P30-OHK	MkjOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NILaUHZKSzVyPUizOU44KG6P	M3rydHNCVkeHUh?=
D-566MG	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVfLS4xSUUN3ME24N\|gvPjJibl2=	MmHyV2FPT0WU
HSC-4	MkP6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVL6OnZLUUN3ME24OFYvPTFibl2=	M4nCUHNCVkeHUh?=
QIMR-WIL	NVTJcJV5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NW\QXFR3UUN3ME24OlIvODNibl2=	NGLtXJNUSU6JRWK=
SW954	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXvJR\|UxRTh4Mz6xOkBvVQ>?	NHnufGVUSU6JRWK=
HGC-27	Ml2xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVjJR\|UxRTh5Mj6zOEBvVQ>?	MXfTRW5ITVJ?
HH	NEDqNIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NY\WcW9XUUN3ME24PVQvOTJibl2=	NVP5Z4VlW0GQR1XS
KE-37	Mk[wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2rH[WlEPTB;OEm0MlYzKG6P	NW\QfoJZW0GQR1XS
SK-N-DZ	M13CUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWjJR\|UxRTlyMD60N{BvVQ>?	NWjWfIU6W0GQR1XS
J-RT3-T3-5	NHT1TXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NV7iXVhHUUN3ME25NVAvPDlibl2=	NVzHWJJJW0GQR1XS
A427	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1zJUGlEPTB;OUKwMlg1KG6P	NV3TTIh6W0GQR1XS
ECC10	M2rPSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFHZdnRKSzVyPUm0OU45PyCwTR?=	NHzxSnVUSU6JRWK=
EW-1	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkexTWM2OD17NEeuNlYhdk1?	NWrIbVZ[W0GQR1XS
MIA-PaCa-2	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVfwU3h3UUN3ME25OFkvOTJibl2=	M4PKXXNCVkeHUh?=
HCC2218	NVLTcItYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1PHfmlEPTB;OUW4MlQ5KG6P	MWXTRW5ITVJ?
HAL-01	NFrQPXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHridWNKSzVyPUm2PE4xPCCwTR?=	NUftO4dvW0GQR1XS
RD	M4rXTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1\EWWlEPTB;OUe0MlQ2KG6P	MXTTRW5ITVJ?
SK-N-AS	Mnz0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NF3IW\|lKSzVyPUm4PE4yKG6P	MVPTRW5ITVJ?
ML-2	NIrtN2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUnuV3M2UUN3ME2xMlAxPDB5IN88US=>	M1nHcHNCVkeHUh?=
MEL-HO	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWHEU3YyUUN3ME2xMlAxPTh{IN88US=>	NWKxTnk3W0GQR1XS
MS-1	M1TxNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWTJR\|UxRTFwMEC2NVch\|ryP	MnLnV2FPT0WU
NCI-SNU-1	NYHlUldRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHe5[WpKSzVyPUGuNFI{OzFizszN	M3vnZnNCVkeHUh?=
8505C	NX7EeppqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYjJR\|UxRTFwMEKzN\|Eh\|ryP	NEO5OYtUSU6JRWK=
MN-60	M3PqfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXnJR\|UxRTFwMEK2PEDPxE1?	M1zpNXNCVkeHUh?=
SAS	M1XLPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWHpcotJUUN3ME2xMlA1ODhzIN88US=>	M3X5fHNCVkeHUh?=
EFM-19	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYHm[XhZUUN3ME2xMlA1QDd7IN88US=>	M1PX[HNCVkeHUh?=
Ca9-22	NHrHfFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoDWTWM2OD1zLkC1NVA4KM7:TR?=	NWPrPWx{W0GQR1XS
NBsusSR	MmDBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHvpXopKSzVyPUGuNFUyPjZizszN	MUjTRW5ITVJ?
NB13	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHy0SYxKSzVyPUGuNFU2ODFizszN	M3;OSHNCVkeHUh?=
SF295	M1;GWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFH6VINKSzVyPUGuNFY3OjRizszN	M2DGdnNCVkeHUh?=
U-2-OS	M1fQVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWL6N2tkUUN3ME2xMlA4QTFzIN88US=>	MX3TRW5ITVJ?
NCI-H526	M4juU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn\uTWM2OD1zLkC4NlkyKM7:TR?=	M4W1XnNCVkeHUh?=
KMOE-2	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4m1dWlEPTB;MT6wPVQzOiEQvF2=	M1vJNXNCVkeHUh?=
RCM-1	NWrldZEyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3e3dmlEPTB;MT6xNlExOiEQvF2=	Mk\1V2FPT0WU
MC116	NYfYe3JyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1ruWGlEPTB;MT6xN\|YzOSEQvF2=	M3Tue3NCVkeHUh?=
NCI-H1092	NV;sRYhnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGLMXopKSzVyPUGuNVU1ODZizszN	NIXMPI5USU6JRWK=
EW-3	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnXETWM2OD1zLkG3NlEzKM7:TR?=	MVzTRW5ITVJ?
HCT-116	MmXsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFWzTFJKSzVyPUGuNVc4PSEQvF2=	NFi5T3FUSU6JRWK=
MC-IXC	NGDGTnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MY\JR\|UxRTFwMUe4PFEh\|ryP	MYfTRW5ITVJ?
LB1047-RCC	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYrQNW1qUUN3ME2xMlE5OzF{IN88US=>	NWj0TY1iW0GQR1XS
VM-CUB-1	NHnSV5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{XGdmlEPTB;MT6xPVExQCEQvF2=	NXG5RW9MW0GQR1XS
NB5	NX\aNndQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MnT5TWM2OD1zLkG5PFU3KM7:TR?=	M2LuWHNCVkeHUh?=
SKG-IIIa	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4r0e2lEPTB;MT6yN\|Q3PCEQvF2=	NXvsUZlEW0GQR1XS
HO-1-N-1	NVP0WIJiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYLiWIg1UUN3ME2xMlI{QDN3IN88US=>	NEPTc29USU6JRWK=
EFO-27	NVv3PGpUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWrJR\|UxRTFwMkWwOFMh\|ryP	NFLuTINUSU6JRWK=
MHH-NB-11	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXrJR\|UxRTFwMkizNlkh\|ryP	M1vkUHNCVkeHUh?=
SW620	MlPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2\IfWlEPTB;MT6yPVAyQCEQvF2=	MXPTRW5ITVJ?
MOLT-16	Ml\US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUfJR\|UxRTFwMkm3PVch\|ryP	M1K5WnNCVkeHUh?=
NTERA-S-cl-D1	M2WyVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml3PTWM2OD1zLkOxO\|YyKM7:TR?=	Mnf4V2FPT0WU
VA-ES-BJ	NIjldHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1HqbWlEPTB;MT6zNlQ4PyEQvF2=	NELVbXNUSU6JRWK=
HCC1419	M3TXe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnHrTWM2OD1zLkO0NFI4KM7:TR?=	M2rNfnNCVkeHUh?=
NCI-H69	Mnf6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWqxd3pKUUN3ME2xMlM1OTF{IN88US=>	M3jMfHNCVkeHUh?=
DEL	NUPFOI9HT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFLXW3NKSzVyPUGuN\|UyPjJizszN	NUHFN49uW0GQR1XS
LXF-289	M{DxOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXnvdpdwUUN3ME2xMlM2OjRizszN	M1rFT3NCVkeHUh?=
EW-11	NFPte5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MknvTWM2OD1zLkO2NFI3KM7:TR?=	NWK2NoRXW0GQR1XS
KP-4	NXv0bXZpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXfJR\|UxRTFwM{ewPFUh\|ryP	MlTFV2FPT0WU
NOS-1	NUfkN2d[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWTaXlZPUUN3ME2xMlQyOTl2IN88US=>	MVjTRW5ITVJ?
SK-NEP-1	NUmwZ3hCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUHJR\|UxRTFwNEG2PVMh\|ryP	Mn\0V2FPT0WU
LAMA-84	NEPXNVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2DROWlEPTB;MT60N\|k1PSEQvF2=	NGLNRVBUSU6JRWK=
ES5	MnfQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmPMTWM2OD1zLkS0N{DPxE1?	MWLTRW5ITVJ?
HuO9	NF64UIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYjJR\|UxRTFwNEWzOlIh\|ryP	MnnSV2FPT0WU
COLO-684	NHzScXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIf4eotKSzVyPUGuOFYyOThizszN	MUTTRW5ITVJ?
EW-24	NEPKVJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYTqb3lRUUN3ME2xMlQ3PTNzIN88US=>	NVXaN5VQW0GQR1XS
BV-173	NGGyRlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUPmbIpMUUN3ME2xMlQ4OjlzIN88US=>	NEGwTIVUSU6JRWK=
NCI-H1770	M33CXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoLnTWM2OD1zLkS4OVM3KM7:TR?=	M4PQW3NCVkeHUh?=
HuP-T4	MnPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4\0dWlEPTB;MT60PVMh\|ryP	MWfTRW5ITVJ?
TYK-nu	M2nJ[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mm\ZTWM2OD1zLkS5PFUyKM7:TR?=	NIrrbJZUSU6JRWK=
YH-13	NXXKdHpDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4XyTWlEPTB;MT60PVg6PCEQvF2=	NGHJeGJUSU6JRWK=
H4	NHnLb\|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoDhTWM2OD1zLkWwPVEzKM7:TR?=	Ml7jV2FPT0WU
OVCAR-8	NXr1dYFCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mkf3TWM2OD1zLkW0OFc4KM7:TR?=	M2XOenNCVkeHUh?=
NCI-H23	NFLvXFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4jMOmlEPTB;MT61OFY1PSEQvF2=	MoHRV2FPT0WU
ES7	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NW\vbJg{UUN3ME2xMlU1Pzd\|IN88US=>	NXGyRVYxW0GQR1XS
COR-L88	M{TFOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXG0O\|h5UUN3ME2xMlU3PDJ2IN88US=>	MmraV2FPT0WU
TI-73	NGn2cGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYLJR\|UxRTFwNUmwOkDPxE1?	NGLQfHZUSU6JRWK=
RT-112	Moe0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWDIR2U5UUN3ME2xMlU6Ojh2IN88US=>	M4TmZ3NCVkeHUh?=
HuO-3N1	NGTCTFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIT3U\|BKSzVyPUGuOVk{QDVizszN	MoPTV2FPT0WU
HC-1	MmHTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVfVWmhPUUN3ME2xMlU6QDZ4IN88US=>	NGHZ[JNUSU6JRWK=
HT55	MmCyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWnrNJJ4UUN3ME2xMlY2OTNzIN88US=>	MlrlV2FPT0WU
IA-LM	M3LD[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2fyTmlEPTB;MT62PVI4QCEQvF2=	NHjBeZRUSU6JRWK=
EM-2	Mk[4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NF3VU5VKSzVyPUGuO\|AxOTRizszN	NX;2U4JqW0GQR1XS
MHH-ES-1	Ml32S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4Pwc2lEPTB;MT63NFQ{PSEQvF2=	NILKNHZUSU6JRWK=
CAL-27	Mk\6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV7mOmtbUUN3ME2xMlcxPjJzIN88US=>	NHLlR5pUSU6JRWK=
COLO-800	NHrPb3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEC3O5dKSzVyPUGuO\|EyPzlizszN	NUXaVmtVW0GQR1XS
HCE-T	Mn\ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIHsOmJKSzVyPUGuO\|E2KM7:TR?=	NVPPfnQxW0GQR1XS
CAMA-1	M1SzNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmDXTWM2OD1zLkexPVcyKM7:TR?=	NV6yUZIyW0GQR1XS
LOXIMVI	NVHHWIhtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlHETWM2OD1zLkeyNVEh\|ryP	NU\wRVY3W0GQR1XS
NH-12	Ml3xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn7BTWM2OD1zLkeyOlkyKM7:TR?=	MWDTRW5ITVJ?
TCCSUP	NWraeFNUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVvWNXBCUUN3ME2xMlczQDJ7IN88US=>	MoPJV2FPT0WU
MDA-MB-361	Mon5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NF3YbXZKSzVyPUGuO\|MyPTdizszN	NYnMT4IxW0GQR1XS
EW-16	NGTNXnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4T3PGlEPTB;MT63OFExPyEQvF2=	NYTsZVdEW0GQR1XS
SNU-423	NV[0OYZXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYnJR\|UxRTFwN{W4Nlch\|ryP	Mon5V2FPT0WU
Daoy	M3nuRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWDsNW4xUUN3ME2xMlc3OzF7IN88US=>	MmW2V2FPT0WU
ES4	M1Pjd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYPJR\|UxRTFwN{i3OFEh\|ryP	NUXzZnpWW0GQR1XS
PFSK-1	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVe3em84UUN3ME2xMlgxOzdizszN	NULWeFk2W0GQR1XS
ES3	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlfWTWM2OD1zLkiyOlgyKM7:TR?=	NEHhNWJUSU6JRWK=
ONS-76	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFjObYVKSzVyPUGuPFI5QTdizszN	NWK2TXBTW0GQR1XS
JVM-3	M2Sxcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnzRTWM2OD1zLki1OFUyKM7:TR?=	MWjTRW5ITVJ?
OS-RC-2	Ml75S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3rMU2lEPTB;MT64O\|E2OSEQvF2=	NWrJUWhmW0GQR1XS
COLO-320-HSR	M{XZRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUPJR\|UxRTFwOEixPVch\|ryP	NV\Mc5ZTW0GQR1XS
HN	MoPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUTPZnlrUUN3ME2xMlg5PzJ3IN88US=>	M1jMc3NCVkeHUh?=
HT	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVXJR\|UxRTFwOEi5OFch\|ryP	NX7JPGV[W0GQR1XS
LoVo	Mor4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUfTNlhqUUN3ME2xMlg6QDFizszN	MWDTRW5ITVJ?
CGTH-W-1	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1KwSmlEPTB;MT64PVk1PiEQvF2=	MlvjV2FPT0WU
NB6	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVHJR\|UxRTFwOUGyPVgh\|ryP	NXzteZd3W0GQR1XS
EW-22	NGLCPHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYPjWY8zUUN3ME2xMlkzQDh5IN88US=>	NEPWToFUSU6JRWK=
ES6	M3OyTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVXJbYUyUUN3ME2xMlk{PjNzIN88US=>	NH;B[GhUSU6JRWK=
SCC-15	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGHqPFlKSzVyPUGuPVM5OTlizszN	MVrTRW5ITVJ?
HL-60	NUm0Z\|VWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYXtXmZ{UUN3ME2xMlk{QTB{IN88US=>	NFfsdlVUSU6JRWK=
human HOP-92	NFHtfVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{n4cWlEPTB;MT65OFA3PSEQvF2=	M3;DbHNCVkeHUh?=
SW626	NIPadZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoHnTWM2OD1zLkm0PFk6KM7:TR?=	NXvwcotwW0GQR1XS
HEC-1	M3i4emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mo[0TWM2OD1zLkm1N\|Yh\|ryP	NXHPcmxVW0GQR1XS
LB2241-RCC	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYHJR\|UxRTFwOUiyN\|Eh\|ryP	MnPGV2FPT0WU
Ramos-2G6-4C10	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXPnbII4UUN3ME2xMlk6PDl\|IN88US=>	Mnu3V2FPT0WU
A101D	M3TFXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHfmc4FKSzVyPUKuNlA{ODNizszN	NEi2NHpUSU6JRWK=
NCI-H446	NUC0fHlvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlTqTWM2OD1{LkC0OVk6KM7:TR?=	MVTTRW5ITVJ?
SBC-5	NGG3e3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEntR25KSzVyPUKuNFYyPDdizszN	MUPTRW5ITVJ?
HOS	MmLvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHfFO4VKSzVyPUKuNFc3PTNizszN	MXnTRW5ITVJ?
K5	MojVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVnQO4dOUUN3ME2yMlA4QDFzIN88US=>	NXHBUXdvW0GQR1XS
HLE	M3S3Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVHRPIxmUUN3ME2yMlA5PTJ7IN88US=>	M4TJXXNCVkeHUh?=
HSC-2	NHHmVINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUXEUJZzUUN3ME2yMlEzQDl6IN88US=>	MX\TRW5ITVJ?
LCLC-97TM1	NVS0bHZ4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXTJR\|UxRTJwMUS1PFMh\|ryP	NHHSVGVUSU6JRWK=
DMS-273	MlXOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnqyTWM2OD1{LkG0PFM4KM7:TR?=	NUnQUmo1W0GQR1XS
TE-8	NWS2bVg1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkS0TWM2OD1{LkG1O\|Y2KM7:TR?=	NWS2d3BHW0GQR1XS
DSH1	NFf3SGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NX;Dd4pjUUN3ME2yMlE3Ozl6IN88US=>	Ml\QV2FPT0WU
CAL-51	M3ThUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnOzTWM2OD1{LkG2Olk6KM7:TR?=	Mlm2V2FPT0WU
IST-SL1	NIn0b\|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUT2fnAzUUN3ME2yMlE3QDR2IN88US=>	Mn2zV2FPT0WU
GCT	M1TsUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVfiRZVyUUN3ME2yMlE4PzdizszN	M1\1e3NCVkeHUh?=
SW948	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NH3WT4hKSzVyPUKuNVg1PTZizszN	MVzTRW5ITVJ?
NOMO-1	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWrJR\|UxRTJwMUmzNVch\|ryP	MkX2V2FPT0WU
C8166	NFrM[ppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUHJR\|UxRTJwMkGzN\|Qh\|ryP	MoXjV2FPT0WU
OC-314	NYfLPJNbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGXncXZKSzVyPUKuNlMzPTlizszN	MWjTRW5ITVJ?
CAL-39	NYHRVYU{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MX;JR\|UxRTJwMkO2NlYh\|ryP	M2mxXnNCVkeHUh?=
MDA-MB-453	MmLCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{TDRmlEPTB;Mj6yOFI4PSEQvF2=	MmTsV2FPT0WU
A673	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1zLTGlEPTB;Mj6yOVg3OiEQvF2=	MUnTRW5ITVJ?
HTC-C3	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYCwUFFPUUN3ME2yMlI3QDVizszN	M4X4fHNCVkeHUh?=
NCI-H1666	NIO2W5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Ml7DTWM2OD1{LkK4NVEyKM7:TR?=	M{XwUXNCVkeHUh?=
PSN1	M3\nWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFXEOWxKSzVyPUKuNlg6OTNizszN	MmK2V2FPT0WU
GI-1	NFu3RXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NV;HbJA4UUN3ME2yMlMxPTR\|IN88US=>	M{\KV3NCVkeHUh?=
HuH-7	NUHUbpF5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MV3JR\|UxRTJwM{C2N\|ch\|ryP	NH3mUHNUSU6JRWK=
JAR	NEK2XGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVnJR\|UxRTJwM{G5PFch\|ryP	MUfTRW5ITVJ?
5637	M4Tpe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1HFemlEPTB;Mj6zNlEzQSEQvF2=	Mnn4V2FPT0WU
GB-1	NV\odnVCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4[1cGlEPTB;Mj6zNlM{PSEQvF2=	MXzTRW5ITVJ?
KP-N-YS	NEjSdGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M37ifGlEPTB;Mj6zNlYyPSEQvF2=	NUfCN3RQW0GQR1XS
OAW-42	MmrFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVTJR\|UxRTJwM{O0NVYh\|ryP	Mof3V2FPT0WU
8-MG-BA	NVzrWmJIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MX3JR\|UxRTJwM{O5NFYh\|ryP	NXO4SGN3W0GQR1XS
RH-18	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn\GTWM2OD1{LkO1NFIzKM7:TR?=	M3;zUHNCVkeHUh?=
NCI-H1155	M3vo[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWjJR\|UxRTJwM{[3NlUh\|ryP	M2juXnNCVkeHUh?=
NB17	M4\vcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkLwTWM2OD1{LkO4NlQ{KM7:TR?=	NH[yU2RUSU6JRWK=
NCI-H1437	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NH7sSHBKSzVyPUKuOFE5PzNizszN	MUHTRW5ITVJ?
SN12C	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlnETWM2OD1{LkSzNlE1KM7:TR?=	MkT1V2FPT0WU
HSC-3	MnW4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3XnWmlEPTB;Mj60OFUxQSEQvF2=	NHPVXmNUSU6JRWK=
GAMG	M{LQ[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1W1eWlEPTB;Mj60OFU3OSEQvF2=	M{\Mc3NCVkeHUh?=
HT-1080	NEezUlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoDqTWM2OD1{LkS0PFY1KM7:TR?=	M3rWTHNCVkeHUh?=
A549	NXf4cmo1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVHJR\|UxRTJwNES4PVMh\|ryP	MkDjV2FPT0WU
KNS-62	NGKzcFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnLsTWM2OD1{LkS1NFYyKM7:TR?=	M{PUNHNCVkeHUh?=
YKG-1	NETIRY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVzJR\|UxRTJwNEW0N\|ch\|ryP	MYfTRW5ITVJ?
LU-134-A	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3P1Z2lEPTB;Mj60O\|AxQCEQvF2=	NInBc5hUSU6JRWK=
FADU	M4X0R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUjJR\|UxRTJwNEexOlIh\|ryP	NGHXOFZUSU6JRWK=
TGBC11TKB	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXTJR\|UxRTJwNEexO\|ch\|ryP	MV7TRW5ITVJ?
HT-3	M3zuV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NH\GdlJKSzVyPUKuOFk2OzVizszN	MmLlV2FPT0WU
NCI-H2170	NVrXPGZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWfJR\|UxRTJwNUC1OFkh\|ryP	NHT0eYdUSU6JRWK=
Mo-T	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYXYfIJEUUN3ME2yMlUxQTJ5IN88US=>	M2jyOHNCVkeHUh?=
CCRF-CEM	M2DiUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnKwTWM2OD1{LkWzNFQ{KM7:TR?=	MYDTRW5ITVJ?
KU-19-19	NVXsTpJVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV\hXWpZUUN3ME2yMlU{PTF\|IN88US=>	MWLTRW5ITVJ?
NCI-H1048	NGLM[WtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoHiTWM2OD1{LkW1NFI2KM7:TR?=	M{W2UHNCVkeHUh?=
KOSC-2	MmLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4e2OGlEPTB;Mj61OlA4PiEQvF2=	MXHTRW5ITVJ?
A431	NWfWV3pNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFrGR\|RKSzVyPUKuOVY{OzVizszN	MlT1V2FPT0WU
COR-L23	NX\GXm9mT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MULJR\|UxRTJwNUi1OlYh\|ryP	MWjTRW5ITVJ?
MKN28	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYLJR\|UxRTJwNUmwN\|ch\|ryP	MVzTRW5ITVJ?
22RV1	NHHjdo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkmwTWM2OD1{LkW5Nlc1KM7:TR?=	NIXWTnhUSU6JRWK=
ABC-1	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlnVTWM2OD1{Lk[wOFYh\|ryP	MVjTRW5ITVJ?
NCI-H2126	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYnEVHRwUUN3ME2yMlYxQTh2IN88US=>	NInpOVRUSU6JRWK=
DoTc2-4510	Ml3GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXLJR\|UxRTJwNkKxPFUh\|ryP	M2LFUnNCVkeHUh?=
SCC-4	M1LkOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn7YTWM2OD1{Lk[zNFEzKM7:TR?=	M33kUnNCVkeHUh?=
NCI-H661	NGjle5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NG[3cpVKSzVyPUKuOlQxQDVizszN	M3rXd3NCVkeHUh?=
RPMI-2650	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnPCTWM2OD1{Lk[0NVQ{KM7:TR?=	M13UT3NCVkeHUh?=
NCI-H510A	NU\wPWhxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVvJR\|UxRTJwNkS0NlYh\|ryP	NV70bIh3W0GQR1XS
BPH-1	M{LzTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFK1WZdKSzVyPUKuOlU5PSEQvF2=	NYXLcppLW0GQR1XS
M14	M3zlT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVTJR\|UxRTJwNk[5PVMh\|ryP	NGPDPGhUSU6JRWK=
G-402	NWixPGNUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFu1VJZKSzVyPUKuO\|A1PTFizszN	NH;WTGdUSU6JRWK=
AsPC-1	MnrES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHfsVYFKSzVyPUKuO\|EyPyEQvF2=	NFvO[FlUSU6JRWK=
NB12	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXTJR\|UxRTJwN{G3NUDPxE1?	NUO0OYx6W0GQR1XS
SK-HEP-1	Mny4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1XVc2lEPTB;Mj63OFM6OSEQvF2=	NUDkR\|RkW0GQR1XS
U-266	Moe0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEnNe\|dKSzVyPUKuO\|cyOjFizszN	MYLTRW5ITVJ?
AM-38	M{\0Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1izXmlEPTB;Mj63O\|M2PSEQvF2=	NVnSSIJUW0GQR1XS
PC-14	MlvOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn:xTWM2OD1{LkiwOVEh\|ryP	M4[yOHNCVkeHUh?=
EGI-1	M4Doe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2HlfGlEPTB;Mj64NVc1OyEQvF2=	NHv1RphUSU6JRWK=
LS-411N	NXPlS4FST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NW[xSIU3UUN3ME2yMlgzOzNizszN	MWnTRW5ITVJ?
BFTC-905	NFrIXotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3PUNWlEPTB;Mj64OVUzOyEQvF2=	NV74eXhoW0GQR1XS
CaR-1	NHr5cVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NITsUmVKSzVyPUKuPFYh\|ryP	NWP2c\|BlW0GQR1XS
NCI-H292	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYP4V3VmUUN3ME2yMlg3PTl4IN88US=>	MmDMV2FPT0WU
8305C	NVq0S\|V[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3vEOGlEPTB;Mj64OlY1PSEQvF2=	NV\lfHVqW0GQR1XS
SNU-449	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3\ZcmlEPTB;Mj64PVE5OiEQvF2=	M3vxWnNCVkeHUh?=
LCLC-103H	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUPJR\|UxRTJwOUC0N\|gh\|ryP	M124OnNCVkeHUh?=
SW1573	Mk\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV3Le5RDUUN3ME2yMlk3ODh{IN88US=>	M1v2U3NCVkeHUh?=
MLMA	NHXGOnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{m5dGlEPTB;Mj65OlcyPyEQvF2=	NVmxdHM3W0GQR1XS
NCI-H1355	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWfiTmpZUUN3ME2zMlAxPzl4IN88US=>	NUTNVWV7W0GQR1XS
RMG-I	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFPCPVRKSzVyPUOuNFI2QTJizszN	MnjKV2FPT0WU
BB65-RCC	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkTRTWM2OD1\|LkCzN\|E1KM7:TR?=	NXzBZ5BOW0GQR1XS
PC-3	M1rEUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn\aTWM2OD1\|LkCzPFc1KM7:TR?=	M4DWXnNCVkeHUh?=
SF268	MnuyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{jjTWlEPTB;Mz6wOFUzOyEQvF2=	MWjTRW5ITVJ?
NCI-H810	NWfvSoM6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4Tu[mlEPTB;Mz6wOFgzOyEQvF2=	MoW4V2FPT0WU
MEG-01	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NH3iTFlKSzVyPUOuNFYyPjRizszN	MkTPV2FPT0WU
SW13	M4S3fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIq1d3NKSzVyPUOuNFc5PDdizszN	NGfGZ3ZUSU6JRWK=
RH-1	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MX3JR\|UxRTNwMUCyO\|gh\|ryP	MnjxV2FPT0WU
GT3TKB	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NV;OVpR5UUN3ME2zMlEyOjh\|IN88US=>	NIXYNIZUSU6JRWK=
TK10	M3nhcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1iwW2lEPTB;Mz6xN\|czPCEQvF2=	NHHpSWpUSU6JRWK=
T-24	Mk\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYTrUoVFUUN3ME2zMlE2ODdizszN	NGTkeYlUSU6JRWK=
A498	NIDKNnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmPTTWM2OD1\|LkKwPFcyKM7:TR?=	M1jjTnNCVkeHUh?=
GR-ST	NWPQT5lOT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkToTWM2OD1\|LkKyNVM6KM7:TR?=	NFP2PHJUSU6JRWK=
LB2518-MEL	M{PCVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWrJR\|UxRTNwMkKzPVgh\|ryP	Ml:2V2FPT0WU
T47D	Mni4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmXRTWM2OD1\|LkKzOlI4KM7:TR?=	Ml7DV2FPT0WU
NCI-H1651	MkDIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYLa[IpGUUN3ME2zMlI1PjR2IN88US=>	MmD6V2FPT0WU
EC-GI-10	NGXNRYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NULHTYdJUUN3ME2zMlI3OTV\|IN88US=>	NHnrdpFUSU6JRWK=
HT-29	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1TWeGlEPTB;Mz6yOlYyPCEQvF2=	NEHWNlhUSU6JRWK=
GI-ME-N	NHLHOGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUnuTYxzUUN3ME2zMlI6PTFzIN88US=>	NH:5NHNUSU6JRWK=

研究领域